CN107141840A - Novel near-infrared high-quantum-yield dye and preparation and application thereof - Google Patents
Novel near-infrared high-quantum-yield dye and preparation and application thereof Download PDFInfo
- Publication number
- CN107141840A CN107141840A CN201610115507.0A CN201610115507A CN107141840A CN 107141840 A CN107141840 A CN 107141840A CN 201610115507 A CN201610115507 A CN 201610115507A CN 107141840 A CN107141840 A CN 107141840A
- Authority
- CN
- China
- Prior art keywords
- carbon atom
- compound
- iii
- alkyl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 238000006862 quantum yield reaction Methods 0.000 title abstract description 21
- 239000000975 dye Substances 0.000 claims abstract description 54
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 42
- 239000001257 hydrogen Substances 0.000 claims abstract description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 37
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 29
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 28
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 24
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 23
- 125000002252 acyl group Chemical group 0.000 claims abstract description 15
- 150000002367 halogens Chemical class 0.000 claims abstract description 15
- 102000007999 Nuclear Proteins Human genes 0.000 claims abstract description 14
- 108010089610 Nuclear Proteins Proteins 0.000 claims abstract description 14
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 7
- 238000001215 fluorescent labelling Methods 0.000 claims abstract description 6
- 150000001450 anions Chemical group 0.000 claims abstract description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 93
- 238000006243 chemical reaction Methods 0.000 claims description 83
- 238000004440 column chromatography Methods 0.000 claims description 62
- 238000003756 stirring Methods 0.000 claims description 62
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 60
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 43
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical class S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 31
- 238000001816 cooling Methods 0.000 claims description 30
- 239000007787 solid Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 claims description 26
- 150000001721 carbon Chemical group 0.000 claims description 24
- -1 formamido Chemical group 0.000 claims description 18
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 17
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 16
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 12
- 239000000460 chlorine Substances 0.000 claims description 11
- 125000005257 alkyl acyl group Chemical group 0.000 claims description 9
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 9
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 8
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 8
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 229910052801 chlorine Inorganic materials 0.000 claims description 7
- 239000011630 iodine Substances 0.000 claims description 7
- 229910052740 iodine Inorganic materials 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 5
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- 239000011737 fluorine Substances 0.000 claims description 5
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 150000001449 anionic compounds Chemical class 0.000 claims description 2
- 229910001412 inorganic anion Inorganic materials 0.000 claims description 2
- 150000002891 organic anions Chemical class 0.000 claims description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 claims 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 8
- 238000006467 substitution reaction Methods 0.000 claims 8
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 claims 7
- 235000019253 formic acid Nutrition 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 4
- 238000000926 separation method Methods 0.000 claims 4
- 238000001914 filtration Methods 0.000 claims 3
- 238000001291 vacuum drying Methods 0.000 claims 3
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 150000001555 benzenes Chemical class 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract description 16
- 125000000547 substituted alkyl group Chemical group 0.000 abstract description 16
- 125000001033 ether group Chemical group 0.000 abstract description 11
- 230000035790 physiological processes and functions Effects 0.000 abstract description 5
- 231100000053 low toxicity Toxicity 0.000 abstract description 4
- 238000000799 fluorescence microscopy Methods 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 description 316
- 238000000034 method Methods 0.000 description 55
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 52
- 238000012360 testing method Methods 0.000 description 52
- 210000004027 cell Anatomy 0.000 description 31
- 239000002904 solvent Substances 0.000 description 28
- 239000005457 ice water Substances 0.000 description 26
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 24
- 239000012153 distilled water Substances 0.000 description 24
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 24
- 125000004432 carbon atom Chemical group C* 0.000 description 20
- 238000010186 staining Methods 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- 0 **N(*)c(c(*)c1*)c(*)c(CCC2)c1C2=O Chemical compound **N(*)c(c(*)c1*)c(*)c(CCC2)c1C2=O 0.000 description 11
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 8
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 229940041181 antineoplastic drug Drugs 0.000 description 3
- 125000005392 carboxamide group Chemical group NC(=O)* 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- YJYCFJXQNBJTDY-UHFFFAOYSA-N 1-ethyl-2,2,4-trimethylquinolin-7-ol Chemical compound OC1=CC=C2C(C)=CC(C)(C)N(CC)C2=C1 YJYCFJXQNBJTDY-UHFFFAOYSA-N 0.000 description 2
- WFNIFMCSVBADMK-UHFFFAOYSA-N 1-methyl-3,4-dihydro-2h-quinolin-7-ol Chemical compound C1=C(O)C=C2N(C)CCCC2=C1 WFNIFMCSVBADMK-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- MESJRHHDBDCQTH-UHFFFAOYSA-N 3-(dimethylamino)phenol Chemical compound CN(C)C1=CC=CC(O)=C1 MESJRHHDBDCQTH-UHFFFAOYSA-N 0.000 description 2
- 229940018563 3-aminophenol Drugs 0.000 description 2
- BMGSGGYIUOQZBZ-UHFFFAOYSA-N 3-morpholin-4-ylphenol Chemical compound OC1=CC=CC(N2CCOCC2)=C1 BMGSGGYIUOQZBZ-UHFFFAOYSA-N 0.000 description 2
- YNLRDTBLEOQPQL-UHFFFAOYSA-N 3-piperidin-1-ylphenol Chemical compound OC1=CC=CC(N2CCCCC2)=C1 YNLRDTBLEOQPQL-UHFFFAOYSA-N 0.000 description 2
- YQXNCQIIKGZOMK-UHFFFAOYSA-N 6-[4-[7-tert-butyl-5-(4-chloro-3-fluorophenyl)furo[3,2-b]pyridine-2-carbonyl]-3,3-dimethylpiperazin-1-yl]-2,4-dimethylpyridine-3-carboxylic acid Chemical compound C(C)(C)(C)C1=C2C(=NC(=C1)C1=CC(=C(C=C1)Cl)F)C=C(O2)C(=O)N1C(CN(CC1)C1=CC(=C(C(=N1)C)C(=O)O)C)(C)C YQXNCQIIKGZOMK-UHFFFAOYSA-N 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 2
- DQXKOHDUMJLXKH-PHEQNACWSA-N (e)-n-[2-[2-[[(e)-oct-2-enoyl]amino]ethyldisulfanyl]ethyl]oct-2-enamide Chemical compound CCCCC\C=C\C(=O)NCCSSCCNC(=O)\C=C\CCCCC DQXKOHDUMJLXKH-PHEQNACWSA-N 0.000 description 1
- IBODDUNKEPPBKW-UHFFFAOYSA-N 1,5-dibromopentane Chemical compound BrCCCCCBr IBODDUNKEPPBKW-UHFFFAOYSA-N 0.000 description 1
- HUXJXNSHCKHFIL-UHFFFAOYSA-N 1-(2-bromoethoxy)-2-methoxyethane Chemical compound COCCOCCBr HUXJXNSHCKHFIL-UHFFFAOYSA-N 0.000 description 1
- FOZVXADQAHVUSV-UHFFFAOYSA-N 1-bromo-2-(2-bromoethoxy)ethane Chemical compound BrCCOCCBr FOZVXADQAHVUSV-UHFFFAOYSA-N 0.000 description 1
- XHLHPRDBBAGVEG-UHFFFAOYSA-N 1-tetralone Chemical class C1=CC=C2C(=O)CCCC2=C1 XHLHPRDBBAGVEG-UHFFFAOYSA-N 0.000 description 1
- GVLQQPDTOWRBRC-UHFFFAOYSA-N 2-bromo-n-(2-bromoethyl)ethanamine Chemical compound BrCCNCCBr GVLQQPDTOWRBRC-UHFFFAOYSA-N 0.000 description 1
- HPJFXFRNEJHDFR-UHFFFAOYSA-N 22291-04-9 Chemical compound C1=CC(C(N(CCN(C)C)C2=O)=O)=C3C2=CC=C2C(=O)N(CCN(C)C)C(=O)C1=C32 HPJFXFRNEJHDFR-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- WAVOOWVINKGEHS-UHFFFAOYSA-N 3-(diethylamino)phenol Chemical compound CCN(CC)C1=CC=CC(O)=C1 WAVOOWVINKGEHS-UHFFFAOYSA-N 0.000 description 1
- CTGSQPRDMHCIMM-UHFFFAOYSA-N 3-(ethylamino)-4-methylphenol Chemical compound CCNC1=CC(O)=CC=C1C CTGSQPRDMHCIMM-UHFFFAOYSA-N 0.000 description 1
- TVKZDKSHNITMRZ-UHFFFAOYSA-N 3-(ethylamino)phenol Chemical compound CCNC1=CC=CC(O)=C1 TVKZDKSHNITMRZ-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- FOFUWJNBAQJABO-UHFFFAOYSA-N 8-hydroxyjulolidine Chemical compound C1CCN2CCCC3=C2C1=CC=C3O FOFUWJNBAQJABO-UHFFFAOYSA-N 0.000 description 1
- 101800002638 Alpha-amanitin Proteins 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-O C1CC[NH2+]CC1 Chemical compound C1CC[NH2+]CC1 NQRYJNQNLNOLGT-UHFFFAOYSA-O 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N C1NCCNC1 Chemical compound C1NCCNC1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 1
- OGYLUEAFFDTYPA-UHFFFAOYSA-N CC(C(CCc1cc(N(C)CCC2)c2cc11)=C1O1)=C(C=C2)C1=CC2=C Chemical compound CC(C(CCc1cc(N(C)CCC2)c2cc11)=C1O1)=C(C=C2)C1=CC2=C OGYLUEAFFDTYPA-UHFFFAOYSA-N 0.000 description 1
- LWDQECICDBHFEB-UHFFFAOYSA-O CC[N+](CC)=C1C=C2OC(c(c(CC3)c4)ccc4NC(OC(C)(C)C)=O)=C3C(C#N)=C2C=C1 Chemical compound CC[N+](CC)=C1C=C2OC(c(c(CC3)c4)ccc4NC(OC(C)(C)C)=O)=C3C(C#N)=C2C=C1 LWDQECICDBHFEB-UHFFFAOYSA-O 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- KFUIVAHDJGKDBK-UHFFFAOYSA-N Oc1c(CCCN2CCC3)c2c3cc1C(C(F)(F)F)=O Chemical compound Oc1c(CCCN2CCC3)c2c3cc1C(C(F)(F)F)=O KFUIVAHDJGKDBK-UHFFFAOYSA-N 0.000 description 1
- 102000017143 RNA Polymerase I Human genes 0.000 description 1
- 108010013845 RNA Polymerase I Proteins 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 102000014450 RNA Polymerase III Human genes 0.000 description 1
- 108010078067 RNA Polymerase III Proteins 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- RXGJTYFDKOHJHK-UHFFFAOYSA-N S-deoxo-amaninamide Natural products CCC(C)C1NC(=O)CNC(=O)C2Cc3c(SCC(NC(=O)CNC1=O)C(=O)NC(CC(=O)N)C(=O)N4CC(O)CC4C(=O)NC(C(C)C(O)CO)C(=O)N2)[nH]c5ccccc35 RXGJTYFDKOHJHK-UHFFFAOYSA-N 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004007 alpha amanitin Substances 0.000 description 1
- CIORWBWIBBPXCG-SXZCQOKQSA-N alpha-amanitin Chemical compound O=C1N[C@@H](CC(N)=O)C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H]([C@@H](C)[C@@H](O)CO)C(=O)N[C@@H](C2)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@H]1C[S@@](=O)C1=C2C2=CC=C(O)C=C2N1 CIORWBWIBBPXCG-SXZCQOKQSA-N 0.000 description 1
- CIORWBWIBBPXCG-UHFFFAOYSA-N alpha-amanitin Natural products O=C1NC(CC(N)=O)C(=O)N2CC(O)CC2C(=O)NC(C(C)C(O)CO)C(=O)NC(C2)C(=O)NCC(=O)NC(C(C)CC)C(=O)NCC(=O)NC1CS(=O)C1=C2C2=CC=C(O)C=C2N1 CIORWBWIBBPXCG-UHFFFAOYSA-N 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000010859 live-cell imaging Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical class OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229960005502 α-amanitin Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
- C09B57/14—Benzoxanthene dyes; Benzothioxanthene dyes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1059—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
本发明公开了一种新型近红外的高量子产率染料,该染料具有如下结构式I:R1、R2、R6、R7分别独立的为氢、低级烃基、醚基、取代烷基或酰基;R3、R4、R5、R8、R9、R10分别独立的为氢、低级烃基或卤素;R11为氢、甲基、氰基、或三氟甲基;为阴离子;还公开了该染料的制备方法。该染料具有良好的生物相容性、低毒性、较长的荧光发射和很高的荧光量子产率,避免了背景自发荧光,可获得高信噪比的荧光成像图,用于生物体系中核仁RNA荧光标记,对研究与核仁RNA相关的生理学过程有着重要的作用。
The invention discloses a novel near-infrared high quantum yield dye, which has the following structural formula I: R 1 , R 2 , R 6 , and R 7 are independently hydrogen, lower hydrocarbon group, ether group, substituted alkyl group or acyl group; R 3 , R 4 , R 5 , R 8 , R 9 , and R 10 are independently Hydrogen, lower alkyl or halogen; R 11 is hydrogen, methyl, cyano, or trifluoromethyl; It is an anion; the preparation method of the dye is also disclosed. The dye has good biocompatibility, low toxicity, long fluorescence emission and high fluorescence quantum yield, avoids background autofluorescence, and can obtain fluorescence imaging images with high signal-to-noise ratio, and is used for nucleoli in biological systems Fluorescent labeling of RNA plays an important role in the study of physiological processes related to nucleolar RNA.
Description
技术领域technical field
本发明涉及近红外的核仁RNA染料,提供了一种新型近红外的高量子产率的染料、制备及应用。The invention relates to a near-infrared nucleolus RNA dye, and provides a novel near-infrared dye with high quantum yield, preparation and application.
背景技术Background technique
由于其高时空分辨率以及快速和非侵入式操作,小分子荧光染料基于的荧光成像已经成为强大的手段对生命系统中生物现象(比如生物分子检测,标记,癌症诊断和治疗等)的可视化观察。RNA是生命系统中特别重要的生物分子,并且细胞核中的RNA位于核仁中,它们在基因编码,转录和表达起着至关重要的作用。生物化学过程中的许多生理过程包括细胞增殖和分化等都与RNA的功能紧密相关。因此,对RNA实时的成像在生化研究中具有重要的意义。许多荧光成像技术(RNA微注射,荧光原位杂交(FISH)或是绿色荧光蛋白(GFP)及其衍生物黄色荧光蛋白(YFP)标记)已经利用来实现活细胞内RNA可视化,但是这些技术具有差的细胞通透性并且可能影响细胞的正常功能。因此,开发出具有好的光物理性质、高的细胞穿透性和易于操作的小分子染料对RNA选择性成像具有重要意义。Owing to its high spatiotemporal resolution and fast and non-invasive operation, small molecule fluorescent dye-based fluorescence imaging has become a powerful tool for visual observation of biological phenomena (such as biomolecular detection, labeling, cancer diagnosis and treatment, etc.) in living systems. . RNA is a particularly important biomolecule in living systems, and RNA in the nucleus is located in the nucleolus, where they play crucial roles in gene coding, transcription, and expression. Many physiological processes in biochemical processes, including cell proliferation and differentiation, are closely related to the function of RNA. Therefore, real-time imaging of RNA is of great significance in biochemical research. Many fluorescent imaging techniques (RNA microinjection, fluorescence in situ hybridization (FISH) or labeling of green fluorescent protein (GFP) and its derivative yellow fluorescent protein (YFP)) have been utilized to visualize RNA in living cells, but these techniques have Poor cell permeability and may affect normal cell function. Therefore, the development of small molecule dyes with good photophysical properties, high cell penetration and easy manipulation is of great significance for RNA selective imaging.
目前为止,Invitrogen公司的具有绿色荧光发射的RNASelect是唯一用于细胞成像的商用RNA探针,但是其应用不是很广泛,染色选择性较差,荧光波长也比较短,该探针的分子结构及合成方法至今尚未公开。近年来研究人员通过多种努力开发了很多RNA标记的染料。大多数情况下,在活细胞中获得一张满意的RNA成像需要较长的孵育时间(几十分钟甚至几个小时),只有几种具有正电荷的染料能够顺利的进入细胞并对RNA快速成像,并且所报道的染料孵育浓度较高且量子产量也低,而这些高浓度染料可能会影响活细胞的正常生理活动并且与细胞中的背景荧光会产生干扰。重要的是,深红特别是近红外发射的RNA染料比较急需,这是由于在此发射范围特别是NIR生物学窗口(650-900nm)具有最低限度的光损伤、最低限度的背景荧光干扰、降低的光散射和增强的组织穿透深度。因此,开发出新型的具有快速定位、低的孵育浓度、高量子产量、高的光稳定性和近红外发射的RNA染料具有重要的意义。So far, Invitrogen's RNASelect with green fluorescence emission is the only commercial RNA probe for cell imaging, but its application is not very wide, the dyeing selectivity is poor, and the fluorescence wavelength is relatively short. The molecular structure and The method of synthesis has not been disclosed so far. In recent years, researchers have developed many dyes for RNA labeling through various efforts. In most cases, obtaining a satisfactory image of RNA in living cells requires a long incubation time (tens of minutes or even hours), and only a few positively charged dyes can smoothly enter cells and rapidly image RNA , and the reported dye incubation concentration is high and the quantum yield is also low, and these high concentration dyes may affect the normal physiological activities of living cells and interfere with the background fluorescence in the cells. Importantly, RNA dyes emitting deep red, especially near-infrared, are in high demand due to minimal photodamage, minimal background fluorescence interference, reduced Light scattering and enhanced tissue penetration depth. Therefore, it is of great significance to develop new RNA dyes with rapid localization, low incubation concentration, high quantum yield, high photostability and near-infrared emission.
相对常用染料(香豆素、萘二酰亚胺、BODIPY、菁染料等)中,基于氧杂蒽的荧光染料由于其独特的性质而备受关注:波长长、光稳定性好、量子产量高、摩尔消光系数大、合成简单、易于修饰等,广泛地应用于生物医学领域。然而由于其发射波长短、pH敏感性强等缺点,限制了其在活体领域的应用。近年报道的新型长波长氧杂蒽类荧光染料,主要是通过扩展电子共扼体系、引入吸电子基团等手段来使其荧光红移。然而使其得到的结构具有更长的发射的同时还具有高的荧光量子产量是非常困难的。Compared with commonly used dyes (coumarin, naphthalene diimide, BODIPY, cyanine dyes, etc.), xanthene-based fluorescent dyes have attracted much attention due to their unique properties: long wavelength, good photostability, and high quantum yield , large molar extinction coefficient, simple synthesis, easy modification, etc., are widely used in the field of biomedicine. However, its short emission wavelength and strong pH sensitivity limit its application in the in vivo field. The new long-wavelength xanthene fluorescent dyes reported in recent years are mainly red-shifted by expanding the electronic conjugate system and introducing electron-withdrawing groups. However, it is very difficult to obtain structures with longer emission and high fluorescence quantum yield.
发明内容Contents of the invention
本发明要解决的第一个技术问题在于提供一种新型近红外的高量子产率染料。此染料具有良好的生物相容性、低毒性、长的荧光发射波长、优异的化学稳定性以及很高的荧光量子产率。The first technical problem to be solved by the present invention is to provide a novel near-infrared dye with high quantum yield. This dye has good biocompatibility, low toxicity, long fluorescence emission wavelength, excellent chemical stability and high fluorescence quantum yield.
本发明要解决的第二个技术问题在于提供新型近红外的高量子产率染料的制备方法。The second technical problem to be solved by the present invention is to provide a method for preparing a novel near-infrared dye with high quantum yield.
本发明要解决的第三个技术问题在于提供一种新型近红外的高量子产率染料作为近红外的核仁RNA染料的应用。The third technical problem to be solved by the present invention is to provide a new near-infrared dye with high quantum yield as a near-infrared nucleolar RNA dye.
为解决第一个技术问题,本发明一种新型近红外的高量子产率染料,其特征在于,具有如下结构式I:In order to solve the first technical problem, a novel near-infrared high quantum yield dye of the present invention is characterized in that it has the following structural formula I:
R1、R2、R6、R7分别独立的为氢、低级烃基、醚基、取代烷基或酰基;R3、R4、R5、R8、R9、R10分别独立的为氢、低级烃基或卤素;R11为氢、甲基、氰基、或三氟甲基;为阴离子;R 1 , R 2 , R 6 , and R 7 are independently hydrogen, lower hydrocarbon group, ether group, substituted alkyl group or acyl group; R 3 , R 4 , R 5 , R 8 , R 9 , and R 10 are independently Hydrogen, lower alkyl or halogen; R 11 is hydrogen, methyl, cyano, or trifluoromethyl; is an anion;
所述R1、R2、R6、R7中低级烃基为直链、支链或环状;所述低级烃基包含1-6个碳原子;The lower hydrocarbon groups in R 1 , R 2 , R 6 , and R 7 are linear, branched or cyclic; the lower hydrocarbon groups contain 1-6 carbon atoms;
所述醚基中碳原子数为3~6,氧原子数≤2;The number of carbon atoms in the ether group is 3-6, and the number of oxygen atoms is ≤2;
所述取代烷基为直链或支链;所述取代烷基为ω-甲酸酯基取代1-6个碳原子烷基、ω-甲酰胺基取代1-6个碳原子烷基、ω-卤素取代1-6个碳原子烷基、ω-羟基取代1-6个碳原子烷基、ω-氨基取代1-6个碳原子烷基或ω-巯基取代1-6个碳原子烷基;其中,所述ω-甲酸酯基取代1-6个碳原子烷基中甲酸酯基为2-5个碳原子烷基甲酸酯基:所述的ω-甲酰胺基取代1-6个碳原子烷基中甲酰胺基为2-5个碳原子烃基甲酰胺基;The substituted alkyl group is a straight chain or branched chain; the substituted alkyl group is ω-formate group substituted 1-6 carbon atom alkyl, ω-formamide group substituted 1-6 carbon atom alkyl, ω -Halogen substituted 1-6 carbon atom alkyl, ω-hydroxyl substituted 1-6 carbon atom alkyl, ω-amino substituted 1-6 carbon atom alkyl or ω-mercapto substituted 1-6 carbon atom alkyl ; Wherein, the formate group in the ω-formyl group substituting 1-6 carbon atom alkyl groups is a 2-5 carbon atom alkyl formate group: the ω-formamide group replaces 1- The carboxamide group in the 6 carbon atom alkyl group is a 2-5 carbon atom hydrocarbon group carboxamide group;
所述酰基为2-6个碳原子烷基酰基、叔丁氧羰基、苯甲酰基、1-6个碳原子取代苯甲酰基或卤素取代苯甲酰基;The acyl group is an alkylacyl group with 2-6 carbon atoms, a tert-butoxycarbonyl group, a benzoyl group, a benzoyl group with 1-6 carbon atoms or a halogen-substituted benzoyl group;
所述卤素为氟、氯、溴或碘;The halogen is fluorine, chlorine, bromine or iodine;
所述R3、R4、R5、R8、R9、R10中的低级烃基为甲基或乙基;The lower hydrocarbon group in R 3 , R 4 , R 5 , R 8 , R 9 , R 10 is methyl or ethyl;
所述为平衡电荷的任意有机或无机阴离子。said is any organic or inorganic anion that balances the charge.
进一步地,所述结构式I中,R1与R3、R1与R10、R2与R3、R2与R10、R6与R5、R6与R8、R7与R5、R7与R8、R1与R2或R6与R7可以独立形成如下Ia-In结构:Further, in the structural formula I, R 1 and R 3 , R 1 and R 10 , R 2 and R 3 , R 2 and R 10 , R 6 and R 5 , R 6 and R 8 , R 7 and R 5 , R 7 and R 8 , R 1 and R 2 or R 6 and R 7 can independently form the following Ia-In structure:
其中R为氢、甲基或乙基;Y为C、O或NR。Wherein R is hydrogen, methyl or ethyl; Y is C, O or NR.
更进一步地,所述的R1、R2、R6、R7中的低级烃基为甲基、乙基、丙基、异丙基、环丙基、烯丙基、丁基、异丁基或叔丁基;Further, the lower hydrocarbon groups in R 1 , R 2 , R 6 , and R 7 are methyl, ethyl, propyl, isopropyl, cyclopropyl, allyl, butyl, isobutyl or tert-butyl;
所述醚基为CH2CH2OCH3、CH2CH2OCH2CH3、CH2CH2OCH2CH3OH、CH2CH2OCH2CH3OCH3或CH2CH2OCH2CH3OCH2CH3;The ether group is CH 2 CH 2 OCH 3 , CH 2 CH 2 OCH 2 CH 3 , CH 2 CH 2 OCH 2 CH 3 OH, CH 2 CH 2 OCH 2 CH 3 OCH 3 or CH 2 CH 2 OCH 2 CH 3 OCH2CH3 ;
所述ω-2-5个碳原子烷基甲酸酯基取代1-6个碳原子烷基为(CH2)mCOO(CH2)nCH3或(CH2)mCOOC(CH3)3,其中m为1-4,n为0-3;The omega-2-5 carbon atom alkyl formate group is substituted with 1-6 carbon atom alkyl group as (CH 2 ) m COO(CH 2 ) n CH 3 or (CH 2 ) m COOC(CH 3 ) 3 , where m is 1-4, n is 0-3;
所述ω-2-5个碳原子烃基甲酰胺基取代1-6个碳原子烷基为(CH2)mCONH(CH2)nCH3或(CH2)mCON[(CH2)nCH3]2,其中m为1-4,n为0-3;The omega-2-5 carbon atom hydrocarbyl carboxamide group substituting 1-6 carbon atom alkyl group is (CH 2 ) m CONH(CH 2 ) n CH 3 or (CH 2 ) m CON[(CH 2 ) n CH 3 ] 2 , wherein m is 1-4, n is 0-3;
所述ω-卤素取代1-6个碳原子烷基为(CH2)mCl、(CH2)mBr或(CH2)mI,其中m为1-6;The ω-halogen substituted alkyl group with 1-6 carbon atoms is (CH 2 ) m Cl, (CH 2 ) m Br or (CH 2 ) m I, wherein m is 1-6;
所述ω-羟基取代1-6个碳原子烷基为(CH2)mOH,其中m为1-6;The ω-hydroxyl substituted alkyl group with 1-6 carbon atoms is (CH 2 ) m OH, where m is 1-6;
所述ω-氨基取代1-6个碳原子烷基为(CH2)mNH2,其中m为1-6;The ω-amino group substituted with an alkyl group of 1-6 carbon atoms is (CH 2 ) m NH 2 , where m is 1-6;
所述ω-巯基取代1-6个碳原子烷基为(CH2)mSH,其中m为1-6;The ω-mercapto substituted alkyl group with 1-6 carbon atoms is (CH 2 ) m SH, where m is 1-6;
所述2-6个碳原子烷基酰基为乙酰基、丙酰基、丁酰基或叔丁酰基;The 2-6 carbon atom alkyl acyl group is acetyl, propionyl, butyryl or tert-butyryl;
所述1-6个碳原子取代苯甲酰基为甲基取代苯甲酰基、乙基取代苯甲酰基、丙基取代苯甲酰基、丁基取代苯甲酰基或叔丁基取代苯甲酰基;The 1-6 carbon atom substituted benzoyl is methyl substituted benzoyl, ethyl substituted benzoyl, propyl substituted benzoyl, butyl substituted benzoyl or tert-butyl substituted benzoyl;
所述卤素取代苯甲酰基为氯取代苯甲酰基、溴取代苯甲酰基或碘取代苯甲酰基。The halogen-substituted benzoyl is chlorine-substituted benzoyl, bromo-substituted benzoyl or iodine-substituted benzoyl.
为解决第二个技术问题,本发明提供新型近红外的高量子产率染料的制备方法,当结构式I中R11为氢或三氟甲基时,包括如下制备步骤: In order to solve the second technical problem, the present invention provides the preparation method of the high quantum yield dye of novel near-infrared, when R in structural formula I When being hydrogen or trifluoromethyl, comprise following preparation steps:
将1毫摩尔化合物II与1毫摩尔化合物III加入到5-15毫升浓硫酸中,在加热条件下反应1-4小时,冷却后将反应液慢慢滴加20-100倍体积的冰水中,再加入0.01-1倍体积的质量百分浓度为70%的高氯酸,充分搅拌,析出固体,过滤、真空干燥,柱层析分离得产物。Add 1 mmol of compound II and 1 mmol of compound III to 5-15 ml of concentrated sulfuric acid, react under heating for 1-4 hours, and slowly add the reaction solution dropwise to 20-100 times the volume of ice water after cooling. Then add 0.01-1 times volume of perchloric acid with a mass percent concentration of 70%, stir well, precipitate solid, filter, vacuum dry, and separate the product by column chromatography.
其中,所述加热的温度为60-100℃;Wherein, the heating temperature is 60-100°C;
所述化合物II的结构式如下:The structural formula of the compound II is as follows:
所述化合物III的结构式如下:The structural formula of the compound III is as follows:
其中,R1、R2、R6、R7分别独立的为氢、低级烃基、醚基、取代烷基或酰基;R3、R4、R5、R8、R9、R10分别独立的为氢、低级烃基或卤素;R0为氢或三氟甲基。Among them, R 1 , R 2 , R 6 , and R 7 are independently hydrogen, lower hydrocarbon group, ether group, substituted alkyl group or acyl group; R 3 , R 4 , R 5 , R 8 , R 9 , and R 10 are independently R is hydrogen, lower alkyl or halogen ; R is hydrogen or trifluoromethyl.
或,当结构式I中R11为甲基时,包括如下制备步骤:Or, when R in the structural formula I is a methyl group, the following preparation steps are included:
1)将1毫摩尔化合物II与1毫摩尔化合物III加入到5-15毫升浓硫酸中,在加热条件下反应1-4小时,冷却后将反应液慢慢滴加20-100倍体积的冰水中,再加入0.01-1倍体积的质量百分浓度为70%的高氯酸,充分搅拌,析出固体,过滤、真空干燥,柱层析分离得产物1-a;1) Add 1 mmol of compound II and 1 mmol of compound III to 5-15 ml of concentrated sulfuric acid, react for 1-4 hours under heating conditions, and slowly add 20-100 times the volume of ice to the reaction solution after cooling Add 0.01-1 volume of perchloric acid with a mass percentage concentration of 70% to the water, stir well, precipitate solid, filter, vacuum dry, and separate by column chromatography to obtain product 1-a;
2)将1毫摩尔得到的I-a溶于5毫升无水THF中,在N2保护条件下逐滴加入3-6毫升中含有1毫摩尔CH3MgI的THF溶液,常温搅拌24h后,再加入2-5毫升含有1毫摩尔DDQ的THF溶液,继续搅拌1-12h,将反应液旋干后柱层析分离得到产物。2) Dissolve 1 mmol of Ia obtained in 5 ml of anhydrous THF, add dropwise 3-6 ml of THF solution containing 1 mmol of CH 3 MgI under N 2 protection conditions, stir at room temperature for 24 hours, and then add 2-5 ml of a THF solution containing 1 mmol DDQ was continued to stir for 1-12 h, the reaction solution was spin-dried and separated by column chromatography to obtain the product.
其中,所述加热的温度为60-100℃;Wherein, the heating temperature is 60-100°C;
所述化合物II的结构式如下:The structural formula of the compound II is as follows:
所述化合物III的结构式如下:The structural formula of the compound III is as follows:
其中,R1、R2、R6、R7分别独立的为氢、低级烃基、醚基、取代烷基或酰基;R3、R4、R5、R8、R9、R10分别独立的为氢、低级烃基或卤素;R0为氢。Among them, R 1 , R 2 , R 6 , and R 7 are independently hydrogen, lower hydrocarbon group, ether group, substituted alkyl group or acyl group; R 3 , R 4 , R 5 , R 8 , R 9 , and R 10 are independently R is hydrogen, lower hydrocarbon or halogen; R 0 is hydrogen.
或,当结构式I中R11为氰基时,包括如下制备步骤:Or, when R in the structural formula I 11 is a cyano group, comprising the following preparation steps:
①将1毫摩尔化合物II与1毫摩尔化合物III加入到5-15毫升浓硫酸中,在加热条件下反应1-4小时,冷却后将反应液慢慢滴加20-100倍体积的冰水中,再加入0.01-1倍体积的质量百分浓度为70%的高氯酸,充分搅拌,析出固体,过滤、真空干燥,柱层析分离得产物1-a;① Add 1 mmol of compound II and 1 mmol of compound III to 5-15 ml of concentrated sulfuric acid, react for 1-4 hours under heating conditions, and slowly add the reaction solution dropwise to 20-100 times the volume of ice water after cooling , then add 0.01-1 times the volume of perchloric acid with a mass percentage concentration of 70%, stir well, precipitate solids, filter, vacuum dry, and separate by column chromatography to obtain product 1-a;
②将1毫摩尔得到的I-a溶于5-20毫升无水DMF中,再加入1毫摩尔的NaCN,常温搅拌24h后,再加入2-5毫升中含有1毫摩尔DDQ的THF溶液,将反应液旋干后柱层析分离得到产物。②Dissolve 1 mmol of I-a obtained in 5-20 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 hours, then add 2-5 ml of THF solution containing 1 mmol of DDQ, and react The product was separated by column chromatography after spinning to dryness.
其中,所述加热的温度为60-100℃;Wherein, the heating temperature is 60-100°C;
所述化合物II的结构式如下:The structural formula of the compound II is as follows:
所述化合物III的结构式如下:The structural formula of the compound III is as follows:
其中,R1、R2、R6、R7分别独立的为氢、低级烃基、醚基、取代烷基或酰基;R3、R4、R5、R8、R9、R10分别独立的为氢、低级烃基或卤素;R0为氢。Among them, R 1 , R 2 , R 6 , and R 7 are independently hydrogen, lower hydrocarbon group, ether group, substituted alkyl group or acyl group; R 3 , R 4 , R 5 , R 8 , R 9 , and R 10 are independently R is hydrogen, lower hydrocarbon or halogen; R 0 is hydrogen.
进一步地,上述三种制备方法中,所述R1、R2、R6、R7中低级烃基为直链、支链或环状;所述低级烃基包含1-6个碳原子;Further, in the above three preparation methods, the lower hydrocarbon group in R 1 , R 2 , R 6 , and R 7 is linear, branched or cyclic; the lower hydrocarbon group contains 1-6 carbon atoms;
所述醚基中碳原子数为3-6,氧原子数≤2;The number of carbon atoms in the ether group is 3-6, and the number of oxygen atoms is ≤2;
所述取代烷基为直链或支链;所述取代烷基为ω-甲酸酯基取代1-6个碳原子烷基、ω-甲酰胺基取代1-6个碳原子烷基、ω-卤素取代1-6个碳原子烷基、ω-羟基取代1-6个碳原子烷基、ω-氨基取代1-6个碳原子烷基或ω-巯基取代1-6个碳原子烷基;其中所述ω-甲酸酯基取代1-6个碳原子烷基中甲酸酯基为2-5个碳原子烷基甲酸酯基;所述的ω-甲酰胺基取代1-6个碳原子烷基中甲酰胺基为2-5个碳原子烃基甲酰胺基;The substituted alkyl group is a straight chain or branched chain; the substituted alkyl group is ω-formate group substituted 1-6 carbon atom alkyl, ω-formamide group substituted 1-6 carbon atom alkyl, ω -Halogen substituted 1-6 carbon atom alkyl, ω-hydroxyl substituted 1-6 carbon atom alkyl, ω-amino substituted 1-6 carbon atom alkyl or ω-mercapto substituted 1-6 carbon atom alkyl ; Wherein said ω-formyl formate group replaces 1-6 carbon atom alkyl formate group is 2-5 carbon atom alkyl formate group; described ω-formamide group replaces 1-6 The carboxamide group in the carbon atom alkyl group is 2-5 carbon atom hydrocarbon group carboxamide group;
所述酰基为2-6个碳原子烷基酰基、叔丁氧羰基、苯甲酰基、1-6个碳原子取代苯甲酰基或卤素取代苯甲酰基;The acyl group is an alkylacyl group with 2-6 carbon atoms, a tert-butoxycarbonyl group, a benzoyl group, a benzoyl group with 1-6 carbon atoms or a halogen-substituted benzoyl group;
所述卤素为氟、氯、溴或碘;The halogen is fluorine, chlorine, bromine or iodine;
所述R3、R4、R5、R8、R9、R10中的低级烃基为甲基或乙基。The lower hydrocarbon group in R 3 , R 4 , R 5 , R 8 , R 9 , and R 10 is methyl or ethyl.
进一步地,所述化合物II和化合物III可以独立形成如下IIa-IIg和IIIa-IIIg结构:Further, the compound II and compound III can independently form the following IIa-IIg and IIIa-IIIg structures:
其中R为氢、甲基或乙基;Y为C、O或NR。Wherein R is hydrogen, methyl or ethyl; Y is C, O or NR.
优选地,所述R1、R2、R6、R7中的低级烃基为甲基、乙基、丙基、异丙基、环丙基、烯丙基、丁基、异丁基或叔丁基;Preferably, the lower hydrocarbon group in R 1 , R 2 , R 6 , and R 7 is methyl, ethyl, propyl, isopropyl, cyclopropyl, allyl, butyl, isobutyl or tert Butyl;
优选地,所述醚基为CH2CH2OCH3、CH2CH2OCH2CH3、CH2CH2OCH2CH3OH、CH2CH2OCH2CH3OCH3或CH2CH2OCH2CH3OCH2CH3;Preferably, the ether group is CH 2 CH 2 OCH 3 , CH 2 CH 2 OCH 2 CH 3 , CH 2 CH 2 OCH 2 CH 3 OH, CH 2 CH 2 OCH 2 CH 3 OCH 3 or CH 2 CH 2 OCH 2CH3OCH2CH3 ; _ _
优选地,所述ω-2-5个碳原子烷基甲酸酯基取代1-6个碳原子烷基为(CH2)mCOO(CH2)nCH3或(CH2)mCOOC(CH3)3,其中m为1-4,n为0-3;Preferably, the ω-2-5 carbon atom alkyl formate group is substituted with 1-6 carbon atom alkyl group as (CH 2 ) m COO(CH 2 ) n CH 3 or (CH 2 ) m COOC( CH 3 ) 3 , wherein m is 1-4, n is 0-3;
优选地,所述ω-2-5个碳原子烃基甲酰胺基取代1-6个碳原子烷基为(CH2)mCONH(CH2)nCH3或(CH2)mCON[(CH2)nCH3]2,其中m为1-4,n为0-3;Preferably, the ω-2-5 carbon atom hydrocarbyl carboxamide group substituting 1-6 carbon atom alkyl group is (CH 2 ) m CONH(CH 2 ) n CH 3 or (CH 2 ) m CON[(CH 2 ) n CH 3 ] 2 , wherein m is 1-4, n is 0-3;
优选地,所述ω-卤素取代1-6个碳原子烷基为(CH2)mCl、(CH2)mBr或(CH2)mI,其中m为1-6;Preferably, the ω-halogen substituted alkyl group with 1-6 carbon atoms is (CH 2 ) m Cl, (CH 2 ) m Br or (CH 2 ) m I, wherein m is 1-6;
优选地,所述ω-羟基取代1-6个碳原子烷基为(CH2)mOH,其中m为1-6;Preferably, the ω-hydroxyl is substituted with an alkyl group having 1-6 carbon atoms as (CH 2 ) m OH, where m is 1-6;
优选地,所述ω-氨基取代1-6个碳原子烷基为(CH2)mNH2,其中m为1-6;Preferably, the ω-amino group substituting an alkyl group with 1-6 carbon atoms is (CH 2 ) m NH 2 , where m is 1-6;
优选地,所述ω-巯基取代1-6个碳原子烷基为(CH2)mSH,其中m为1-6;Preferably, the ω-mercapto substituted alkyl group with 1-6 carbon atoms is (CH 2 ) m SH, where m is 1-6;
优选地,所述2-6个碳原子烷基酰基为乙酰基、丙酰基、丁酰基或叔丁酰基;Preferably, the 2-6 carbon atom alkyl acyl group is acetyl, propionyl, butyryl or tert-butyryl;
优选地,所述1-6个碳原子取代苯甲酰基为甲基取代苯甲酰基、乙基取代苯甲酰基、丙基取代苯甲酰基、丁基取代苯甲酰基或叔丁基取代苯甲酰基;Preferably, the 1-6 carbon atom substituted benzoyl is methyl substituted benzoyl, ethyl substituted benzoyl, propyl substituted benzoyl, butyl substituted benzoyl or tert-butyl substituted benzoyl Acyl;
优选地,所述卤素取代苯甲酰基为氯取代苯甲酰基、溴取代苯甲酰基或碘取代苯甲酰基。Preferably, the halogen-substituted benzoyl is chlorine-substituted benzoyl, bromo-substituted benzoyl or iodine-substituted benzoyl.
为解决第三个技术问题,本发明保护新型近红外的高量子产率染料作为近红外的核仁RNA染料的应用。To solve the third technical problem, the present invention protects the application of a novel near-infrared high quantum yield dye as a near-infrared nucleolar RNA dye.
进一步地,本发明保护新型近红外的高量子产率染料作为近红外的核仁RNA染料,应用于核仁RNA的荧光标记。Furthermore, the present invention protects a novel near-infrared dye with high quantum yield as a near-infrared nucleolar RNA dye, which is applied to the fluorescent labeling of nucleolar RNA.
一些新的抗癌药物,如顺铂、放线菌素D、α-鹅膏蕈碱等的作用位点是RNA聚合酶,从而诱导细胞的死亡,而RNA聚合酶中,RNA聚合酶I和RNA聚合酶III位于细胞质中,RNA聚合酶II位于细胞核中,因此本发明中的染料通过对核仁RNA进行荧光标记,可以用来筛选不同作用位点的抗癌药物以及对抗癌药物药效的评估。Some new anticancer drugs, such as cisplatin, actinomycin D, α-amanitin, etc., act on RNA polymerase, thereby inducing cell death, and among RNA polymerases, RNA polymerase I and RNA polymerase III is located in the cytoplasm, and RNA polymerase II is located in the nucleus, so the dyes in the present invention can be used to screen anticancer drugs at different sites of action and the efficacy of anticancer drugs by fluorescently labeling nucleolar RNA evaluation of.
本发明基于原料易得的3,4-二氢-1-萘酮衍生物,通过与其对应的水杨醛衍生物在浓硫酸的缩合条件下加热,得到了一系列不对称、非直线型共轭结构的新型氧杂蒽衍生的化合物,此化合物具有较长的荧光发射(近红外荧光),特别是结构中引入的亚甲基结构使其具有较高的荧光量子产率。此外其良好的生物相容性和低毒性,可以对生物体系的大分子(核仁RNA)进行荧光标记,对研究其在生理活性中的作用奠定了重要的基础。The present invention is based on the readily available 3,4-dihydro-1-naphthone derivatives, through heating the corresponding salicylaldehyde derivatives under the condensation conditions of concentrated sulfuric acid to obtain a series of asymmetric, nonlinear co- A novel xanthene-derived compound with a conjugated structure, which has a longer fluorescence emission (near-infrared fluorescence), especially the methylene structure introduced in the structure makes it have a higher fluorescence quantum yield. In addition, its good biocompatibility and low toxicity allow fluorescent labeling of macromolecules (nucleolar RNA) in biological systems, laying an important foundation for studying its role in physiological activities.
本发明的有益效果如下:The beneficial effects of the present invention are as follows:
本发明的具有结构式I的新型近红外的高量子产率染料具有不对称、非直线型的共轭结构,并且具有长的荧光发射(近红外发射)和较高的荧光量子产率,同时也具有良好的生物相容性和低毒性,可以对生物体系尤其是细胞中的重要生物大分子核仁RNA荧光标记,降低了染料孵育浓度,避免了高浓度染料对细胞正常生理功能的干扰,同时避免了背景荧光的干扰从而对生物大分子准确的定位,对于研究核仁RNA相关的生理学过程有着重要的作用。The novel near-infrared high quantum yield dye with structural formula I of the present invention has an asymmetric, non-linear conjugated structure, and has long fluorescence emission (near-infrared emission) and higher fluorescence quantum yield, and also With good biocompatibility and low toxicity, it can fluorescently label nucleolar RNA, an important biomacromolecule in biological systems, especially cells, which reduces the concentration of dye incubation and avoids the interference of high-concentration dyes on the normal physiological functions of cells. Avoiding the interference of background fluorescence and thus accurately locating biological macromolecules plays an important role in studying the physiological processes related to nucleolar RNA.
附图说明Description of drawings
下面结合附图对本发明的具体实施方式作进一步详细的说明。The specific implementation manners of the present invention will be further described in detail below in conjunction with the accompanying drawings.
图1示出本发明实例3中荧光染料I-6将A549细胞染色后的图。FIG. 1 shows a picture of A549 cells stained with fluorescent dye I-6 in Example 3 of the present invention.
图2示出本发明实例7中荧光染料I-15将A549细胞染色后的图。Fig. 2 shows a picture of A549 cells stained with fluorescent dye I-15 in Example 7 of the present invention.
图3示出本发明实例15中荧光染料I-29将A549细胞染色后的图。FIG. 3 shows the staining of A549 cells with fluorescent dye I-29 in Example 15 of the present invention.
图4示出本发明实例16中荧光染料I-30将A549细胞染色后的图。Fig. 4 shows a picture of A549 cells stained with fluorescent dye I-30 in Example 16 of the present invention.
图5示出本发明实例27中荧光染料I-42将A549细胞染色后的图。FIG. 5 shows the staining of A549 cells with fluorescent dye I-42 in Example 27 of the present invention.
图6示出本发明实例28中荧光染料I-43将A549细胞染色后的图。FIG. 6 shows the staining of A549 cells with fluorescent dye I-43 in Example 28 of the present invention.
图7示出本发明实例37中荧光染料I-54将A549细胞染色后的图。FIG. 7 shows the staining of A549 cells with fluorescent dye I-54 in Example 37 of the present invention.
图8示出本发明实例37中荧光染料I-54将HeLa细胞染色后的图。FIG. 8 shows the staining of HeLa cells with fluorescent dye I-54 in Example 37 of the present invention.
图9示出本发明实例40中荧光染料I-78将A549细胞染色后的图。FIG. 9 shows the staining of A549 cells with fluorescent dye I-78 in Example 40 of the present invention.
图10示出本发明实例40中荧光染料I-78将HeLa细胞染色后的图。FIG. 10 shows the staining of HeLa cells with fluorescent dye I-78 in Example 40 of the present invention.
图11示出本发明实例42中荧光染料I-95将HeLa细胞染色后的图。FIG. 11 shows the staining of HeLa cells with fluorescent dye I-95 in Example 42 of the present invention.
图12示出本发明实例54中荧光染料I-191将HeLa细胞染色后的图。FIG. 12 shows the staining of HeLa cells with fluorescent dye I-191 in Example 54 of the present invention.
图13示出本发明实例62中荧光染料I-255将HeLa细胞染色后的图。FIG. 13 shows the staining of HeLa cells with fluorescent dye I-255 in Example 62 of the present invention.
图14示出本发明实例77中荧光染料I-393将HeLa细胞染色后的图。FIG. 14 shows the staining of HeLa cells with fluorescent dye I-393 in Example 77 of the present invention.
图15示出本发明实例37的荧光染料I-54和实例40中的荧光染料I-78分别和I-78加DNA酶和RNA酶消化后并与市售DNA、RNA染料对比图。Figure 15 shows the fluorescent dye I-54 in Example 37 of the present invention and the fluorescent dye I-78 in Example 40 respectively and I-78 after digestion with DNase and RNase and compared with commercially available DNA and RNA dyes.
图16示出本发明实例37的荧光染料I-54和实例40中的荧光染料I-78分别与市售RNA染料SYTO RNASelect的细胞染色效果对比图。Figure 16 shows the comparison of the cell staining effect of the fluorescent dye I-54 in Example 37 of the present invention and the fluorescent dye I-78 in Example 40 with the commercially available RNA dye SYTO RNASelect.
具体实施方式detailed description
为了更清楚地说明本发明,下面结合优选实施例和附图对本发明做进一步的说明。附图中相似的部件以相同的附图标记进行表示。本领域技术人员应当理解,下面所具体描述的内容是说明性的而非限制性的,不应以此限制本发明的保护范围。In order to illustrate the present invention more clearly, the present invention will be further described below in conjunction with preferred embodiments and accompanying drawings. Similar parts in the figures are denoted by the same reference numerals. Those skilled in the art should understand that the content specifically described below is illustrative rather than restrictive, and should not limit the protection scope of the present invention.
实施例1:Example 1:
将0.193g(0.001mol)的化合物II-1和0.161g(0.001mol)的化合物III-1分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.343g化合物I-1,产率82%。ESI MS:理论计算m/z:319.18,实际测试m/z:319.20。λabs. max/nm=615nm,λem max/nm=638nm,Фf=0.80。0.193 g (0.001 mol) of compound II-1 and 0.161 g (0.001 mol) of compound III-1 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.343g of compound I-1, with a yield of 82%. ESI MS: theoretical calculation m/z: 319.18, actual test m/z: 319.20. λ abs. max /nm = 615nm, λ em max /nm = 638nm, Ф f = 0.80.
将0.418g(0.001mol)的化合物I-1、0.202g(0.001mol)的二碳酸二叔丁酯和0.101g(0.001mol)的三乙胺分别加入到10毫升的无水二氯甲烷中,常温条件下搅拌24h,在真空条件下除去溶剂,干燥,柱层析纯化分离得到0.440g化合物I-2,产率85%。ESI MS:理论计算m/z:419.23,实际测试m/z:419.25。λabs. max/nm=620nm,λem max/nm=645nm,Фf=0.82。0.418g (0.001mol) of compound I-1, 0.202g (0.001mol) of di-tert-butyl dicarbonate and 0.101g (0.001mol) of triethylamine were added to 10 ml of anhydrous dichloromethane respectively, After stirring for 24 hours at room temperature, the solvent was removed under vacuum, dried and purified by column chromatography to obtain 0.440 g of compound I-2 with a yield of 85%. ESI MS: theoretical calculation m/z: 419.23, actual test m/z: 419.25. λ abs. max /nm = 620nm, λ em max /nm = 645nm, Ф f = 0.82.
将0.518g(0.001mmol)化合物I-2溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.223g化合物I-3,产率42%。ESI MS:理论计算m/z:433.25,实际测试m/z:433.20。λabs. max/nm=622nm,λem max/nm=648nm,Фf=0.85。Dissolve 0.518g (0.001mmol) of compound I-2 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing 1 mmol DDQ solution in THF was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.223 g of compound I-3 with a yield of 42%. ESI MS: theoretical calculation m/z: 433.25, actual test m/z: 433.20. λ abs. max /nm = 622nm, λ em max /nm = 648nm, Ф f = 0.85.
实施例2Example 2
化合物III-11根据文献(Org.Lett.,2011,13,6488-6491)由商用化合物III-1与碘乙烷制备,产率50%。Compound III-11 was prepared from commercial compound III-1 and ethyl iodide according to literature (Org. Lett., 2011, 13, 6488-6491), with a yield of 50%.
将0.217g(0.001mol)的化合物II-2和0.189g(0.001mol)的化合物III-2分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.399g化合物I-4,产率85%。ESI MS:理论计算m/z:371.21,实际测试m/z:371.24。λabs. max/nm=635nm,λem max/nm=658nm,Фf=0.73。0.217 g (0.001 mol) of compound II-2 and 0.189 g (0.001 mol) of compound III-2 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.399 g of compound I-4, with a yield of 85%. ESI MS: Theoretical calculation m/z: 371.21, actual test m/z: 371.24. λ abs. max /nm = 635nm, λ em max /nm = 658nm, Ф f = 0.73.
将0.470g(0.001mmol)化合物I-4溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.198g化合物I-5,产率41%。ESI MS:理论计算m/z:385.23,实际测试m/z:383.27。λabs. max/nm=636nm,λem max/nm=660nm,Фf=0.75。Dissolve 0.470 g (0.001 mmol) of compound I-4 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing 1 mmol DDQ solution in THF was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.198 g of compound I-5 with a yield of 41%. ESI MS: theoretical calculation m/z: 385.23, actual test m/z: 383.27. λ abs. max /nm = 636nm, λ em max /nm = 660nm, Ф f = 0.75.
实施例3Example 3
化合物II-3根据文献(J.Am.Chem.Soc.,2007,129,9986-9998)由7-羟基-1-甲基-1,2,3,4-四氢喹啉制备,产率76%。化合物III-3根据文献(Org.Lett.,2011,13,6488–6491)由商用化合物III-1与碘甲烷制备,产率42%。Compound II-3 was prepared from 7-hydroxy-1-methyl-1,2,3,4-tetrahydroquinoline according to the literature (J.Am.Chem.Soc., 2007,129,9986-9998), the yield 76%. Compound III-3 was prepared from commercial compound III-1 and methyl iodide according to literature (Org. Lett., 2011, 13, 6488-6491), with a yield of 42%.
将0.191g(0.001mol)的化合物II-3和0.189g(0.001mol)的化合物III-3分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.391g化合物I-6,产率88%。ESI MS:理论计算m/z:345.20,实际测试m/z:345.26。λabs. max/nm=633nm,λem max/nm=656nm,Фf=0.78。0.191 g (0.001 mol) of compound II-3 and 0.189 g (0.001 mol) of compound III-3 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.391 g of compound I-6, with a yield of 88%. ESI MS: Theoretical calculation m/z: 345.20, actual test m/z: 345.26. λ abs. max /nm = 633nm, λ em max /nm = 656nm, Ф f = 0.78.
将0.444g(0.001mmol)化合物I-6溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.202g化合物I-7,产率44%。ESI MS:理论计算m/z:359.21,实际测试m/z:359.17。λabs. max/nm=634nm,λem max/nm=658nm,Фf=0.80。Dissolve 0.444g (0.001mmol) of compound I-6 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing 1 mmol DDQ solution in THF was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.202 g of compound I-7 with a yield of 44%. ESI MS: theoretical calculation m/z: 359.21, actual test m/z: 359.17. λ abs. max /nm = 634nm, λ em max /nm = 658nm, Ф f = 0.80.
实施例4Example 4
化合物II-4根据文献(J.Am.Chem.Soc.,2007,129,9986-9998)由7-羟基-1-乙基-2,2,4-三甲基-1,2-二氢喹啉制备,产率71%。化合物III-4根据文献(Org.Lett.,2011,13,6488–6491)由商用化合物III-1与1-碘乙烷制备,产率45%。Compound II-4 was synthesized from 7-hydroxyl-1-ethyl-2,2,4-trimethyl-1,2-dihydro Quinoline was prepared with a yield of 71%. Compound III-4 was prepared from commercial compound III-1 and 1-iodoethane according to literature (Org. Lett., 2011, 13, 6488-6491), with a yield of 45%.
将0.231g(0.001mol)的化合物II-4和0.217g(0.001mol)的化合物III-4分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.446g化合物I-8,产率87%。ESI MS:理论计算m/z:413.26,实际测试m/z:413.32。λabs. max/nm=648nm,λem max/nm=674nm,Фf=0.76。0.231 g (0.001 mol) of compound II-4 and 0.217 g (0.001 mol) of compound III-4 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.446 g of compound I-8, with a yield of 87%. ESI MS: theoretical calculation m/z: 413.26, actual test m/z: 413.32. λ abs. max /nm = 648nm, λ em max /nm = 674nm, Ф f = 0.76.
将0.512g(0.001mmol)化合物I-8溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.226g化合物I-9,产率43%。ESI MS:理论计算m/z:359.21,实际测试m/z:359.17。λabs. max/nm=650nm,λem max/nm=678nm,Фf=0.73。Dissolve 0.512g (0.001mmol) of compound I-8 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing 1 mmol DDQ solution in THF was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.226 g of compound I-9 with a yield of 43%. ESI MS: theoretical calculation m/z: 359.21, actual test m/z: 359.17. λ abs. max /nm = 650nm, λ em max /nm = 678nm, Ф f = 0.73.
实施例5Example 5
化合物II-5根据文献(J.Am.Chem.Soc.,2007,129,9986-9998)由3-N,N-二乙氨基苯酚制备,产率75%。化合物III-5根据文献(Org.Lett.,2011,13,6488–6491)由商用化合物III-1与1-溴-2-(2-甲氧基乙氧基)乙烷制备,产率30%。Compound II-5 was prepared from 3-N,N-diethylaminophenol according to literature (J.Am.Chem.Soc., 2007, 129, 9986-9998), with a yield of 75%. Compound III-5 was prepared from commercial compound III-1 and 1-bromo-2-(2-methoxyethoxy)ethane according to literature (Org.Lett., 2011, 13, 6488–6491), yield 30 %.
将0.165g(0.001mol)的化合物II-5和0.365g(0.001mol)的化合物III-5分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.440g化合物I-10,产率74%。ESI MS:理论计算m/z:495.29,实际测试m/z:495.23。λabs. max/nm=622nm,λem max/nm=648nm,Фf=0.80。0.165 g (0.001 mol) of compound II-5 and 0.365 g (0.001 mol) of compound III-5 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.440 g of compound I-10, with a yield of 74%. ESI MS: Theoretical calculation m/z: 495.29, actual test m/z: 495.23. λ abs. max /nm = 622nm, λ em max /nm = 648nm, Ф f = 0.80.
将0.594g(0.001mmol)化合物I-10溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.255g化合物I-11,产率42%。ESI MS:理论计算m/z:509.30,实际测试m/z:509.27。λabs. max/nm=623nm,λem max/nm=650nm,Фf=0.83。Dissolve 0.594g (0.001mmol) of compound I-10 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing The THF solution of 1 mmol DDQ was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.255 g of compound I-11 with a yield of 42%. ESI MS: Theoretical calculation m/z: 509.30, actual test m/z: 509.27. λ abs. max /nm = 623nm, λ em max /nm = 650nm, Ф f = 0.83.
实施例6Example 6
化合物II-6根据文献(J.Am.Chem.Soc.,2007,129,9986-9998)由7-羟基-1-(4-正丁酸)-1,2,3,4-四氢喹啉制备,产率62%。化合物III-6根据文献(Org.Lett.,2011,13,6488–6491)由商用化合物III-1分别与1-氯-3-溴丙烷、碘甲烷制备,产率28%。Compound II-6 was synthesized from 7-hydroxyl-1-(4-n-butyric acid)-1,2,3,4-tetrahydroquinone according to literature (J.Am.Chem.Soc., 2007,129,9986-9998) Phenol was prepared with a yield of 62%. Compound III-6 was prepared from commercial compound III-1 with 1-chloro-3-bromopropane and methyl iodide respectively according to literature (Org. Lett., 2011, 13, 6488-6491), with a yield of 28%.
将0.291g(0.001mol)的化合物II-6和0.215g(0.001mol)的化合物III-6分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.393g化合物I-12,产率69%。ESI MS:理论计算m/z:471.26,实际测试m/z:471.21。λabs. max/nm=632nm,λem max/nm=658nm,Фf=0.74。0.291 g (0.001 mol) of compound II-6 and 0.215 g (0.001 mol) of compound III-6 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.393 g of compound I-12, with a yield of 69%. ESI MS: Theoretical calculation m/z: 471.26, actual test m/z: 471.21. λ abs. max /nm = 632nm, λ em max /nm = 658nm, Ф f = 0.74.
将0.570g(0.001mmol)化合物I-12溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.222g化合物I-13,产率38%。ESI MS:理论计算m/z:485.28,实际测试m/z:485.32。λabs. max/nm=633nm,λem max/nm=662nm,Фf=0.76。Dissolve 0.570 g (0.001 mmol) of compound I-12 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing 1 mmol DDQ solution in THF was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.222 g of compound I-13 with a yield of 38%. ESI MS: Theoretical calculation m/z: 485.28, actual test m/z: 485.32. λ abs. max /nm = 633nm, λ em max /nm = 662nm, Ф f = 0.76.
实施例7Example 7
化合物II-7根据文献(J.Am.Chem.Soc.,2007,129,9986-9998)由3-(1-哌啶基)苯酚制备,产率83%。化合物III-7根据文献(Org.Lett.,2011,13,6488–6491)由商用化合物III-1与1-氯-3-溴丙烷制备,产率20%。Compound II-7 was prepared from 3-(1-piperidinyl)phenol according to literature (J.Am.Chem.Soc., 2007, 129, 9986-9998), with a yield of 83%. Compound III-7 was prepared from commercial compound III-1 and 1-chloro-3-bromopropane according to literature (Org. Lett., 2011, 13, 6488-6491), with a yield of 20%.
将0.205g(0.001mol)的化合物II-7和0.241g(0.001mol)的化合物III-7分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.454g化合物I-14,产率89%。ESI MS:理论计算m/z:411.24,实际测试m/z:411.20。λabs. max/nm=630nm,λem max/nm=656nm,Фf=0.74。0.205 g (0.001 mol) of compound II-7 and 0.241 g (0.001 mol) of compound III-7 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.454 g of compound I-14, with a yield of 89%. ESI MS: theoretical calculation m/z: 411.24, actual test m/z: 411.20. λ abs. max /nm = 630nm, λ em max /nm = 656nm, Ф f = 0.74.
将0.510g(0.001mmol)化合物I-14溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.220g化合物I-15,产率42%。ESI MS:理论计算m/z:425.26,实际测试m/z:425.22。λabs. max/nm=630nm,λem max/nm=660nm,Фf=0.75。Dissolve 0.510 g (0.001 mmol) of compound I-14 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing 1 mmol DDQ solution in THF was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.220 g of compound I-15 with a yield of 42%. ESI MS: Theoretical calculation m/z: 425.26, actual test m/z: 425.22. λ abs. max /nm = 630nm, λ em max /nm = 660nm, Ф f = 0.75.
实施例8Example 8
化合物II-8根据文献(J.Am.Chem.Soc.,2007,129,9986-9998)由3-(4-吗啉基)苯酚制备,产率83%。化合物III-8根据文献(Org.Lett.,2011,13,6488–6491)由商用化合物III-1与1,5-二溴戊烷制备,产率14%。Compound II-8 was prepared from 3-(4-morpholinyl)phenol according to literature (J.Am.Chem.Soc., 2007, 129, 9986-9998), with a yield of 83%. Compound III-8 was prepared from commercial compound III-1 and 1,5-dibromopentane according to literature (Org. Lett., 2011, 13, 6488-6491), with a yield of 14%.
将0.207g(0.001mol)的化合物II-8和0.229g(0.001mol)的化合物III-8分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.400g化合物I-16,产率80%。ESI MS:理论计算m/z:401.22,实际测试m/z:401.20。λabs. max/nm=624nm,λem max/nm=652nm,Фf=0.83。0.207 g (0.001 mol) of compound II-8 and 0.229 g (0.001 mol) of compound III-8 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.400 g of compound I-16 with a yield of 80%. ESI MS: theoretical calculation m/z: 401.22, actual test m/z: 401.20. λ abs. max /nm = 624nm, λ em max /nm = 652nm, Ф f = 0.83.
将0.500g(0.001mmol)化合物I-16溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.200g化合物I-17,产率39%。ESI MS:理论计算m/z:415.24,实际测试m/z:415.27。λabs. max/nm=621nm,λem max/nm=654nm,Фf=0.84。Dissolve 0.500 g (0.001 mmol) of compound I-16 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing The THF solution of 1 mmol DDQ was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.200 g of compound I-17 with a yield of 39%. ESI MS: Theoretical calculation m/z: 415.24, actual test m/z: 415.27. λ abs. max /nm = 621nm, λ em max /nm = 654nm, Ф f = 0.84.
实施例9Example 9
化合物II-9根据文献(J.Am.Chem.Soc.,2007,129,9986-9998)由3-(1-哌嗪)苯酚制备,产率68%。化合物III-9根据文献(Org.Lett.,2011,13,6488–6491)由商用化合物III-1与1-溴-2-(2-溴乙氧基)乙烷制备,产率11%。Compound II-9 was prepared from 3-(1-piperazine)phenol according to literature (J.Am.Chem.Soc., 2007, 129, 9986-9998), with a yield of 68%. Compound III-9 was prepared from commercial compound III-1 and 1-bromo-2-(2-bromoethoxy)ethane according to literature (Org. Lett., 2011, 13, 6488-6491), with a yield of 11%.
将0.206g(0.001mol)的化合物II-9和0.231g(0.001mol)的化合物III-9分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.381g化合物I-18,产率76%。ESI MS:理论计算m/z:402.22,实际测试m/z:402.25。λabs. max/nm=625nm,λem max/nm=653nm,Фf=0.85。0.206 g (0.001 mol) of compound II-9 and 0.231 g (0.001 mol) of compound III-9 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.381 g of compound I-18 with a yield of 76%. ESI MS: theoretical calculation m/z: 402.22, actual test m/z: 402.25. λ abs. max /nm = 625nm, λ em max /nm = 653nm, Ф f = 0.85.
将0.501g(0.001mmol)化合物I-18溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.191g化合物I-19,产率37%。ESI MS:理论计算m/z:416.23,实际测试m/z:416.19。λabs. max/nm=624nm,λem max/nm=655nm,Фf=0.87。Dissolve 0.501 g (0.001 mmol) of compound I-18 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing 1 mmol DDQ solution in THF was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.191 g of compound I-19 with a yield of 37%. ESI MS: theoretical calculation m/z: 416.23, actual test m/z: 416.19. λ abs. max /nm = 624nm, λ em max /nm = 655nm, Ф f = 0.87.
实施例10Example 10
化合物II-10根据文献(J.Am.Chem.Soc.,2007,129,9986-9998)由间氨基苯酚制备,产率48%。Compound II-10 was prepared from m-aminophenol according to literature (J.Am.Chem.Soc., 2007, 129, 9986-9998), with a yield of 48%.
将0.137g(0.001mol)的化合物II-10和0.189g(0.001mol)的化合物III-3分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.304g化合物I-20,产率78%。ESI MS:理论计算m/z:291.15,实际测试m/z:291.20。λabs. max/nm=617nm,λem max/nm=636nm,Фf=0.82。0.137 g (0.001 mol) of compound II-10 and 0.189 g (0.001 mol) of compound III-3 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.304 g of compound I-20, with a yield of 78%. ESI MS: Theoretical calculation m/z: 291.15, actual test m/z: 291.20. λ abs. max /nm = 617nm, λ em max /nm = 636nm, Ф f = 0.82.
将0.390g(0.001mol)的化合物I-20、0.202g(0.001mol)的二碳酸二叔丁酯和0.101g(0.001mol)的三乙胺分别加入到10毫升的无水二氯甲烷中,常温条件下搅拌24h,在真空条件下除去溶剂,干燥,柱层析纯化分离得到0.392g化合物I-21,产率80%。ESI MS:理论计算m/z:391.20,实际测试m/z:391.25。λabs. max/nm=620nm,λem max/nm=644nm,Фf=0.85。0.390g (0.001mol) of compound I-20, 0.202g (0.001mol) of di-tert-butyl dicarbonate and 0.101g (0.001mol) of triethylamine were added to 10 ml of anhydrous dichloromethane respectively, After stirring for 24 hours at room temperature, the solvent was removed under vacuum, dried, and purified by column chromatography to obtain 0.392 g of compound I-21 with a yield of 80%. ESI MS: theoretical calculation m/z: 391.20, actual test m/z: 391.25. λ abs. max /nm = 620nm, λ em max /nm = 644nm, Ф f = 0.85.
将0.490g(0.001mmol)化合物I-21溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.186g化合物I-22,产率37%。ESI MS:理论计算m/z:405.22,实际测试m/z:405.24。λabs. max/nm=620nm,λem max/nm=646nm,Фf=0.87。Dissolve 0.490 g (0.001 mmol) of compound I-21 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing 1 mmol DDQ solution in THF was continued to stir for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.186 g of compound I-22 with a yield of 37%. ESI MS: Theoretical calculation m/z: 405.22, actual test m/z: 405.24. λ abs. max /nm = 620nm, λ em max /nm = 646nm, Ф f = 0.87.
实施例11Example 11
化合物II-10根据文献(J.Am.Chem.Soc.,2007,129,9986-9998)由3-乙氨基-4-甲基苯酚制备,产率56%。Compound II-10 was prepared from 3-ethylamino-4-methylphenol according to literature (J.Am.Chem.Soc., 2007, 129, 9986-9998), with a yield of 56%.
将0.179g(0.001mol)的化合物II-11和0.217g(0.001mol)的化合物III-4分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.359g化合物I-23,产率78%。ESI MS:理论计算m/z:361.23,实际测试m/z:361.18。λabs. max/nm=623nm,λem max/nm=648nm,Фf=0.87。0.179 g (0.001 mol) of compound II-11 and 0.217 g (0.001 mol) of compound III-4 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.359 g of compound I-23, with a yield of 78%. ESI MS: theoretical calculation m/z: 361.23, actual test m/z: 361.18. λ abs. max /nm = 623nm, λ em max /nm = 648nm, Ф f = 0.87.
将0.460g(0.001mmol)化合物I-23溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.166g化合物I-24,产率35%。ESI MS:理论计算m/z:375.24,实际测试m/z:375.29。λabs. max/nm=621nm,λem max/nm=650nm,Фf=0.89。Dissolve 0.460 g (0.001 mmol) of compound I-23 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing 1 mmol DDQ solution in THF was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.166 g of compound I-24 with a yield of 35%. ESI MS: Theoretical calculation m/z: 375.24, actual test m/z: 375.29. λ abs. max /nm = 621nm, λ em max /nm = 650nm, Ф f = 0.89.
实施例12Example 12
化合物II-12根据文献(J.Am.Chem.Soc.,2007,129,9986-9998)由4-氯-3-二乙胺基苯酚制备,产率56%;化合物III-10根据文献(Org.Lett.,2011,13,6488–6491)由商用化合物III-1与双(2-溴乙基)胺制备,产率8%。Compound II-12 was prepared from 4-chloro-3-diethylaminophenol according to the literature (J.Am.Chem.Soc., 2007,129,9986-9998), with a yield of 56%; Compound III-10 was prepared according to the literature ( Org. Lett., 2011, 13, 6488–6491) was prepared from commercial compound III-1 and bis(2-bromoethyl)amine with a yield of 8%.
将0.227g(0.001mol)的化合物II-11和0.230g(0.001mol)的化合物III-4分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应2h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.375g化合物I-25,产率72%。ESI MS:理论计算m/z:422.20,实际测试m/z:422.23。λabs. max/nm=624nm,λem max/nm=652nm,Фf=0.83。0.227 g (0.001 mol) of compound II-11 and 0.230 g (0.001 mol) of compound III-4 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 2 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.375 g of compound I-25, with a yield of 72%. ESI MS: theoretical calculation m/z: 422.20, actual test m/z: 422.23. λ abs. max /nm = 624nm, λ em max /nm = 652nm, Ф f = 0.83.
将0.521g(0.001mmol)化合物I-25溶于5毫升无水THF,氮气保护下逐滴加入3毫升中含有1毫摩尔CH3MgI的THF溶液,常温反应24小时,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.176g化合物I-26,产率33%。ESI MS:理论计算m/z:436.22,实际测试m/z:436.19。λabs. max/nm=622nm,λem max/nm=655nm,Фf=0.85。Dissolve 0.521g (0.001mmol) of compound I-25 in 5 ml of anhydrous THF, add dropwise to 3 ml of THF solution containing 1 mmol of CH 3 MgI under nitrogen protection, react at room temperature for 24 hours, then add 2 ml of CH 3 MgI containing 1 mmol DDQ solution in THF was stirred for 1 h, the solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.176 g of compound I-26 with a yield of 33%. ESI MS: Theoretical calculation m/z: 436.22, actual test m/z: 436.19. λ abs. max /nm = 622nm, λ em max /nm = 655nm, Ф f = 0.85.
实施例13Example 13
将0.518g(0.001mmol)化合物I-2溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.196g化合物I-27,产率36%。ESI MS:理论计算m/z:444.23,实际测试m/z:444.21。λabs. max/nm=690nm,λem max/nm=720nm,Фf=0.35。Dissolve 0.518g (0.001mmol) of compound I-2 in 5ml of anhydrous DMF, then add 1mmol of NaCN, stir at room temperature for 24h, then add 2ml of THF solution containing 1mmol of DDQ, and continue stirring for 1h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.196 g of compound I-27, with a yield of 36%. ESI MS: theoretical calculation m/z: 444.23, actual test m/z: 444.21. λ abs. max /nm = 690nm, λ em max /nm = 720nm, Ф f = 0.35.
实施例14Example 14
将0.470g(0.001mmol)化合物I-4溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.198g化合物I-28,产率40%。ESI MS:理论计算m/z:396.21,实际测试m/z:396.23。λabs. max/nm=698nm,λem max/nm=732nm,Фf=0.25。Dissolve 0.470 g (0.001 mmol) of compound I-4 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.198 g of compound I-28, with a yield of 40%. ESI MS: theoretical calculation m/z: 396.21, actual test m/z: 396.23. λ abs. max /nm = 698nm, λ em max /nm = 732nm, Ф f = 0.25.
实施例15Example 15
将0.444g(0.001mmol)化合物I-6溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.197g化合物I-29,产率42%。ESI MS:理论计算m/z:370.19,实际测试m/z:370.17。λabs. max/nm=705nm,λem max/nm=730nm,Фf=0.30。Dissolve 0.444 g (0.001 mmol) of compound I-6 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.197 g of compound I-29, with a yield of 42%. ESI MS: theoretical calculation m/z: 370.19, actual test m/z: 370.17. λ abs. max /nm = 705nm, λ em max /nm = 730nm, Ф f = 0.30.
实施例16Example 16
将0.512g(0.001mmol)化合物I-8溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.236g化合物I-30,产率44%。ESI MS:理论计算m/z:438.25,实际测试m/z:438.29。λabs. max/nm=715nm,λem max/nm=750nm,Фf=0.20。Dissolve 0.512 g (0.001 mmol) of compound I-8 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.236 g of compound I-30, with a yield of 44%. ESI MS: theoretical calculation m/z: 438.25, actual test m/z: 438.29. λ abs. max /nm = 715nm, λ em max /nm = 750nm, Ф f = 0.20.
实施例17Example 17
将0.594g(0.001mmol)化合物I-10溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.254g化合物I-31,产率41%。ESI MS:理论计算m/z:520.28,实际测试m/z:520.30。λabs. max/nm=694nm,λem max/nm=612nm,Фf=0.33。Dissolve 0.594 g (0.001 mmol) of compound I-10 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.254 g of compound I-31, with a yield of 41%. ESI MS: theoretical calculation m/z: 520.28, actual test m/z: 520.30. λ abs. max /nm = 694nm, λ em max /nm = 612nm, Ф f = 0.33.
实施例18Example 18
将0.570g(0.001mmol)化合物I-12溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.226g化合物I-32,产率38%。ESI MS:理论计算m/z:496.26,实际测试m/z:496.30。λabs. max/nm=706nm,λem max/nm=734nm,Фf=0.26。Dissolve 0.570 g (0.001 mmol) of compound I-12 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.226 g of compound I-32 with a yield of 38%. ESI MS: Theoretical calculation m/z: 496.26, actual test m/z: 496.30. λ abs. max /nm = 706nm, λ em max /nm = 734nm, Ф f = 0.26.
实施例19Example 19
将0.510g(0.001mmol)化合物I-14溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.235g化合物I-33,产率44%。ESI MS:理论计算m/z:436.24,实际测试m/z:436.22。λabs. max/nm=705nm,λem max/nm=735nm,Фf=0.25。Dissolve 0.510 g (0.001 mmol) of compound I-14 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.235 g of compound I-33, with a yield of 44%. ESI MS: theoretical calculation m/z: 436.24, actual test m/z: 436.22. λ abs. max /nm = 705nm, λ em max /nm = 735nm, Ф f = 0.25.
实施例20Example 20
将0.500g(0.001mmol)化合物I-16溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.221g化合物I-34,产率42%。ESI MS:理论计算m/z:426.22,实际测试m/z:426.27。λabs. max/nm=694nm,λem max/nm=725nm,Фf=0.34。Dissolve 0.500 g (0.001 mmol) of compound I-16 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.221 g of compound I-34 with a yield of 42%. ESI MS: theoretical calculation m/z: 426.22, actual test m/z: 426.27. λ abs. max /nm = 694nm, λ em max /nm = 725nm, Ф f = 0.34.
实施例21Example 21
将0.501g(0.001mmol)化合物I-18溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.200g化合物I-35,产率38%。ESI MS:理论计算m/z:427.21,实际测试m/z:427.19。λabs. max/nm=696nm,λem max/nm=725nm,Фf=0.37。Dissolve 0.501 g (0.001 mmol) of compound I-18 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.200 g of compound I-35 with a yield of 38%. ESI MS: Theoretical calculation m/z: 427.21, actual test m/z: 427.19. λ abs. max /nm = 696nm, λ em max /nm = 725nm, Ф f = 0.37.
实施例22Example 22
将0.490g(0.001mmol)化合物I-21溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.185g化合物I-36,产率35%。ESI MS:理论计算m/z:430.21,实际测试m/z:430.24。λabs. max/nm=694nm,λem max/nm=720nm,Фf=0.37。Dissolve 0.490 g (0.001 mmol) of compound I-21 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.185 g of compound I-36, with a yield of 35%. ESI MS: Theoretical calculation m/z: 430.21, actual test m/z: 430.24. λ abs. max /nm = 694nm, λ em max /nm = 720nm, Ф f = 0.37.
实施例23Example 23
将0.460g(0.001mmol)化合物I-23溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.175g化合物I-37,产率36%。ESI MS:理论计算m/z:386.22,实际测试m/z:386.21。λabs. max/nm=694nm,λem max/nm=720nm,Фf=0.39。Dissolve 0.460 g (0.001 mmol) of compound I-23 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.175 g of compound I-37 with a yield of 36%. ESI MS: theoretical calculation m/z: 386.22, actual test m/z: 386.21. λ abs. max /nm = 694nm, λ em max /nm = 720nm, Ф f = 0.39.
实施例24Example 24
将0.521g(0.001mmol)化合物I-25溶于5毫升无水DMF,然后加入1毫摩尔的NaCN,常温搅拌24h后,再加入2毫升中含有1毫摩尔DDQ的THF溶液,继续搅拌1h,在真空条件下除去溶剂,干燥,柱层析分离得到0.191g化合物I-38,产率35%。ESI MS:理论计算m/z:447.19,实际测试m/z:447.17。λabs. max/nm=694nm,λem max/nm=726nm,Фf=0.35。Dissolve 0.521 g (0.001 mmol) of compound I-25 in 5 ml of anhydrous DMF, then add 1 mmol of NaCN, stir at room temperature for 24 h, then add 2 ml of THF solution containing 1 mmol of DDQ, and continue stirring for 1 h. The solvent was removed under vacuum, dried, and separated by column chromatography to obtain 0.191 g of compound I-38 with a yield of 35%. ESI MS: Theoretical calculation m/z: 447.19, actual test m/z: 447.17. λ abs. max /nm = 694nm, λ em max /nm = 726nm, Ф f = 0.35.
实施例25Example 25
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由间二甲基氨基苯酚与三氟乙酸酐制备,产率45%。Compound II-4 was prepared from m-dimethylaminophenol and trifluoroacetic anhydride according to literature (Chem. Eur. J., 2013, 19, 16556-16565), with a yield of 45%.
将0.261g(0.001mol)的化合物II-13和0.161g(0.001mol)的化合物III-1分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.087g化合物I-39,产率18%。ESI MS:理论计算m/z:387.17,实际测试m/z:387.16。λabs. max/nm=674nm,λem max/nm=705nm,Фf=0.48。0.261 g (0.001 mol) of compound II-13 and 0.161 g (0.001 mol) of compound III-1 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.087 g of compound I-39, with a yield of 18%. ESI MS: theoretical calculation m/z: 387.17, actual test m/z: 387.16. λ abs. max /nm = 674nm, λ em max /nm = 705nm, Ф f = 0.48.
将0.486g(0.001mol)的化合物I-39、0.202g(0.001mol)的二碳酸二叔丁酯和0.101g(0.001mol)的三乙胺分别加入到10毫升的无水二氯甲烷中,常温条件下搅拌24h,在真空条件下除去溶剂,干燥,柱层析纯化分离得到0.516g化合物I-40,产率88%。ESI MS:理论计算m/z:487.22,实际测试m/z:487.25。λabs. max/nm=680nm,λem max/nm=710nm,Фf=0.45。0.486g (0.001mol) of compound I-39, 0.202g (0.001mol) of di-tert-butyl dicarbonate and 0.101g (0.001mol) of triethylamine were added to 10 ml of anhydrous dichloromethane respectively, After stirring for 24 hours at room temperature, the solvent was removed under vacuum, dried, and purified by column chromatography to obtain 0.516 g of compound I-40 with a yield of 88%. ESI MS: theoretical calculation m/z: 487.22, actual test m/z: 487.25. λ abs. max /nm = 680nm, λ em max /nm = 710nm, Ф f = 0.45.
实施例26Example 26
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由8-羟基久洛尼定与三氟乙酸酐制备,产率52%。Compound II-4 was prepared from 8-hydroxyjulolidine and trifluoroacetic anhydride according to literature (Chem. Eur. J., 2013, 19, 16556-16565), with a yield of 52%.
将0.285g(0.001mol)的化合物II-14和0.189g(0.001mol)的化合物III-2分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.113g化合物I-41,产率21%。ESI MS:理论计算m/z:439.20,实际测试m/z:439.18。λabs. max/nm=686nm,λem max/nm=720nm,Фf=0.35。0.285 g (0.001 mol) of compound II-14 and 0.189 g (0.001 mol) of compound III-2 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.113 g of compound I-41, with a yield of 21%. ESI MS: Theoretical calculation m/z: 439.20, actual test m/z: 439.18. λ abs. max /nm = 686nm, λ em max /nm = 720nm, Ф f = 0.35.
实施例27Example 27
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由7-羟基-1-甲基-1,2,3,4-四氢喹啉与三氟乙酸酐制备,产率51%。Compound II-4 was prepared from 7-hydroxy-1-methyl-1,2,3,4-tetrahydroquinoline and trifluoroacetic anhydride according to literature (Chem.Eur.J.,2013,19,16556-16565) , yield 51%.
将0.259g(0.001mol)的化合物II-15和0.189g(0.001mol)的化合物III-3分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.128g化合物I-42,产率25%。ESI MS:理论计算m/z:413.18,实际测试m/z:413.19。λabs. max/nm=695nm,λem max/nm=720nm,Фf=0.38。0.259 g (0.001 mol) of compound II-15 and 0.189 g (0.001 mol) of compound III-3 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.128 g of compound I-42, with a yield of 25%. ESI MS: Theoretical calculation m/z: 413.18, actual test m/z: 413.19. λ abs. max /nm = 695nm, λ em max /nm = 720nm, Ф f = 0.38.
实施例28Example 28
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由7-羟基-1-乙基-2,2,4-三甲基-1,2-二氢喹啉与三氟乙酸酐制备,产率49%。Compound II-4 was synthesized from 7-hydroxyl-1-ethyl-2,2,4-trimethyl-1,2-dihydroquinoline according to literature (Chem.Eur.J.,2013,19,16556-16565) Prepared with trifluoroacetic anhydride in 49% yield.
将0.299g(0.001mol)的化合物II-16和0.217g(0.001mol)的化合物III-4分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.133g化合物I-43,产率23%。ESI MS:理论计算m/z:481.25,实际测试m/z:481.27。λabs. max/nm=705nm,λem max/nm=738nm,Фf=0.30。0.299 g (0.001 mol) of compound II-16 and 0.217 g (0.001 mol) of compound III-4 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.133 g of compound I-43, with a yield of 23%. ESI MS: theoretical calculation m/z: 481.25, actual test m/z: 481.27. λ abs. max /nm = 705nm, λ em max /nm = 738nm, Ф f = 0.30.
实施例29Example 29
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由间二甲基氨基苯酚与三氟乙酸酐制备,产率44%。Compound II-4 was prepared from m-dimethylaminophenol and trifluoroacetic anhydride according to literature (Chem. Eur. J., 2013, 19, 16556-16565), with a yield of 44%.
将0.233g(0.001mol)的化合物II-17和0.365g(0.001mol)的化合物III-5分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.086g化合物I-44,产率13%。ESI MS:理论计算m/z:563.27,实际测试m/z:563.29。λabs. max/nm=686nm,λem max/nm=602nm,Фf=0.42。0.233 g (0.001 mol) of compound II-17 and 0.365 g (0.001 mol) of compound III-5 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.086 g of compound I-44, with a yield of 13%. ESI MS: Theoretical calculation m/z: 563.27, actual test m/z: 563.29. λ abs. max /nm = 686nm, λ em max /nm = 602nm, Ф f = 0.42.
实施例30Example 30
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由7-羟基-1-(4-正丁酸乙酯)-1,2,3,4-四氢喹啉与三氟乙酸酐制备,产率41%。Compound II-4 was synthesized from 7-hydroxyl-1-(4-n-butyric acid ethyl ester)-1,2,3,4-tetrahydroquinone according to literature (Chem.Eur.J.,2013,19,16556-16565) morphine and trifluoroacetic anhydride, yield 41%.
将0.359g(0.001mol)的化合物II-18和0.215g(0.001mol)的化合物III-6分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.064g化合物I-45,产率10%。ESI MS:理论计算m/z:539.25,实际测试m/z:539.21。λabs. max/nm=694nm,λem max/nm=724nm,Фf=0.35。0.359 g (0.001 mol) of compound II-18 and 0.215 g (0.001 mol) of compound III-6 were added to 5 ml of concentrated sulfuric acid, and heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.064 g of compound I-45, with a yield of 10%. ESI MS: theoretical calculation m/z: 539.25, actual test m/z: 539.21. λ abs. max /nm = 694nm, λ em max /nm = 724nm, Ф f = 0.35.
实施例31Example 31
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由3-(1-哌啶基)苯酚与三氟乙酸酐制备,产率47%。Compound II-4 was prepared from 3-(1-piperidinyl)phenol and trifluoroacetic anhydride according to literature (Chem. Eur. J., 2013, 19, 16556-16565), with a yield of 47%.
将0.273g(0.001mol)的化合物II-19和0.241g(0.001mol)的化合物III-7分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.104g化合物I-46,产率18%。ESI MS:理论计算m/z:479.23,实际测试m/z:479.21。λabs. max/nm=695nm,λem max/nm=724nm,Фf=0.35。0.273 g (0.001 mol) of compound II-19 and 0.241 g (0.001 mol) of compound III-7 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.104 g of compound I-46, with a yield of 18%. ESI MS: Theoretical calculation m/z: 479.23, actual test m/z: 479.21. λ abs. max /nm = 695nm, λ em max /nm = 724nm, Ф f = 0.35.
实施例32Example 32
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由3-(4-吗啉基)苯酚与三氟乙酸酐制备,产率46%。Compound II-4 was prepared from 3-(4-morpholinyl)phenol and trifluoroacetic anhydride according to literature (Chem. Eur. J., 2013, 19, 16556-16565), with a yield of 46%.
将0.275g(0.001mol)的化合物II-20和0.229g(0.001mol)的化合物III-8分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.096g化合物I-47,产率17%。ESI MS:理论计算m/z:469.21,实际测试m/z:469.27。λabs. max/nm=682nm,λem max/nm=715nm,Фf=0.48。0.275 g (0.001 mol) of compound II-20 and 0.229 g (0.001 mol) of compound III-8 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.096 g of compound I-47, with a yield of 17%. ESI MS: theoretical calculation m/z: 469.21, actual test m/z: 469.27. λ abs. max /nm = 682nm, λ em max /nm = 715nm, Ф f = 0.48.
实施例33Example 33
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由3-(1-哌嗪)苯酚与三氟乙酸酐制备,产率35%。Compound II-4 was prepared from 3-(1-piperazine)phenol and trifluoroacetic anhydride according to literature (Chem. Eur. J., 2013, 19, 16556-16565), with a yield of 35%.
将0.274g(0.001mol)的化合物II-21和0.231g(0.001mol)的化合物III-9分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.085g化合物I-48,产率15%。ESI MS:理论计算m/z:470.20,实际测试m/z:470.18。λabs. max/nm=685nm,λem max/nm=715nm,Фf=0.45。0.274 g (0.001 mol) of compound II-21 and 0.231 g (0.001 mol) of compound III-9 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.085 g of compound I-48, with a yield of 15%. ESI MS: theoretical calculation m/z: 470.20, actual test m/z: 470.18. λ abs. max /nm = 685nm, λ em max /nm = 715nm, Ф f = 0.45.
实施例34Example 34
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由间氨基苯酚与三氟乙酸酐制备,产率33%。Compound II-4 was prepared from m-aminophenol and trifluoroacetic anhydride according to literature (Chem. Eur. J., 2013, 19, 16556-16565), with a yield of 33%.
将0.205g(0.001mol)的化合物II-22和0.189g(0.001mol)的化合物III-3分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.055g化合物I-49,产率12%。ESI MS:理论计算m/z:359.14,实际测试m/z:359.18。λabs. max/nm=680nm,λem max/nm=708nm,Фf=0.50。0.205 g (0.001 mol) of compound II-22 and 0.189 g (0.001 mol) of compound III-3 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.055 g of compound I-49, with a yield of 12%. ESI MS: Theoretical calculation m/z: 359.14, actual test m/z: 359.18. λ abs. max /nm = 680nm, λ em max /nm = 708nm, Ф f = 0.50.
将0.458g(0.001mol)的化合物I-49、0.202g(0.001mol)的二碳酸二叔丁酯和0.101g(0.001mol)的三乙胺分别加入到10毫升的无水二氯甲烷中,常温条件下搅拌24h,在真空条件下除去溶剂,干燥,柱层析纯化分离得到0.463g化合物I-50,产率83%。ESI MS:理论计算m/z:459.19,实际测试m/z:459.25。λabs. max/nm=684nm,λem max/nm=710nm,Фf=0.47。0.458g (0.001mol) of compound I-49, 0.202g (0.001mol) of di-tert-butyl dicarbonate and 0.101g (0.001mol) of triethylamine were added to 10 ml of anhydrous dichloromethane respectively, After stirring for 24 hours at room temperature, the solvent was removed under vacuum, dried, and purified by column chromatography to obtain 0.463 g of compound I-50 with a yield of 83%. ESI MS: Theoretical calculation m/z: 459.19, actual test m/z: 459.25. λ abs. max /nm = 684nm, λ em max /nm = 710nm, Ф f = 0.47.
实施例35Example 35
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由间乙基氨基苯酚与三氟乙酸酐制备,产率38%。Compound II-4 was prepared from m-ethylaminophenol and trifluoroacetic anhydride according to literature (Chem. Eur. J., 2013, 19, 16556-16565), with a yield of 38%.
将0.247g(0.001mol)的化合物II-23和0.217g(0.001mol)的化合物III-4分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.074g化合物I-51,产率14%。ESI MS:理论计算m/z:429.21,实际测试m/z:429.27。λabs. max/nm=682nm,λem max/nm=715nm,Фf=0.48。0.247 g (0.001 mol) of compound II-23 and 0.217 g (0.001 mol) of compound III-4 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.074 g of compound I-51, with a yield of 14%. ESI MS: theoretical calculation m/z: 429.21, actual test m/z: 429.27. λ abs. max /nm = 682nm, λ em max /nm = 715nm, Ф f = 0.48.
实施例36Example 36
化合物II-4根据文献(Chem.Eur.J.,2013,19,16556-16565)由4-氯-3-二乙胺基苯酚与三氟乙酸酐制备,产率46%。Compound II-4 was prepared from 4-chloro-3-diethylaminophenol and trifluoroacetic anhydride according to literature (Chem. Eur. J., 2013, 19, 16556-16565), with a yield of 46%.
将0.295g(0.001mol)的化合物II-24和0.230g(0.001mol)的化合物III-10分别加入到5毫升的浓硫酸中,然后在100℃条件下加热搅拌,反应4h。冷却后,将反应液缓慢倒入到200毫升冰水中,然后在搅拌的条件下逐滴加入1毫升高氯酸(70%),再加入大量的蒸馏水,静置后析出固体,过滤、真空干燥,柱层析纯化分离得到0.094g化合物I-52,产率16%。ESI MS:理论计算m/z:490.19,实际测试m/z:490.21。λabs. max/nm=684nm,λem max/nm=715nm,Фf=0.42。0.295 g (0.001 mol) of compound II-24 and 0.230 g (0.001 mol) of compound III-10 were added to 5 ml of concentrated sulfuric acid, and then heated and stirred at 100° C. for 4 h. After cooling, the reaction solution was slowly poured into 200 ml of ice water, then 1 ml of perchloric acid (70%) was added dropwise under stirring, and a large amount of distilled water was added, and solids were precipitated after standing, filtered, and vacuum-dried , purified by column chromatography to obtain 0.094 g of compound I-52, with a yield of 16%. ESI MS: Theoretical calculation m/z: 490.19, actual test m/z: 490.21. λ abs. max /nm = 684nm, λ em max /nm = 715nm, Ф f = 0.42.
实施例37Example 37
按照实施例1的方法,由1毫摩尔化合物II-1分别与1毫摩尔化合物III-2、III-3、III-4、III-6、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-53、I-54、I-55、I-56、I-57、I-58、I-59、I-60,产率分别为83%、85%、84%、87%、88%、83%、81%、80%。According to the method of Example 1, by 1 mmol compound II-1 and 1 mmol compound III-2, III-3, III-4, III-6, III-7, III-8, III-9, III -10 reaction, compounds I-53, I-54, I-55, I-56, I-57, I-58, I-59, I-60 can be prepared respectively, and the yields are 83%, 85% respectively , 84%, 87%, 88%, 83%, 81%, 80%.
实施例38Example 38
按照实施例1的方法,由1毫摩尔化合物I-53、I-54、I-55、I-56、I-57、I-58、I-59、I-60分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-61、I-62、I-63、I-64、I-65、I-66、I-67、I-68,产率分别为41%、43%、44%、45%、47%、43%、42%、43%。According to the method of Example 1, by 1 mmol compound I-53, I-54, I-55, I-56, I-57, I-58, I-59, I-60 and 1 mmol compound CH 3 MgI reaction, compounds I-61, I-62, I-63, I-64, I-65, I-66, I-67, I-68 can be prepared respectively, and the yields are 41%, 43% respectively , 44%, 45%, 47%, 43%, 42%, 43%.
实施例39Example 39
按照实施例1和实施例13的方法,由1毫摩尔化合物I-53、I-54、I-55、I-56、I-57、I-58、I-59、I-60分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-69、I-70、I-71、I-72、I-73、I-74、I-75、I-76,产率分别为31%、33%、34%、35%、37%、35%、33%、30%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-53, I-54, I-55, I-56, I-57, I-58, I-59, I-60 respectively with 1 Millimole compound NaCN reaction, can make compound I-69, I-70, I-71, I-72, I-73, I-74, I-75, I-76 respectively, productive rate is respectively 31%, 33%, 34%, 35%, 37%, 35%, 33%, 30%.
实施例40Example 40
按照实施例25的方法,由1毫摩尔化合物II-13分别与1毫摩尔化合物III-2、III-3、III-4、III-6、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-77、I-78、I-79、I-80、I-81、I-82、I-83、I-84,产率分别为11%、14%、16%、17%、21%、20%、15%、12%。According to the method of Example 25, by 1 mmol compound II-13 and 1 mmol compound III-2, III-3, III-4, III-6, III-7, III-8, III-9, III -10 reaction, compounds I-77, I-78, I-79, I-80, I-81, I-82, I-83, I-84 can be prepared respectively, and the yields are 11%, 14% respectively , 16%, 17%, 21%, 20%, 15%, 12%.
实施例41Example 41
按照实施例1的方法,由1毫摩尔化合物II-2分别与1毫摩尔化合物III-1、III-3、III-4、III-6、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-85、I-86、I-87、I-88、I-89、I-90、I-91、I-92,产率分别为80%、86%、89%、85%、88%、83%、82%、81%。According to the method of Example 1, by 1 mmol compound II-2 and 1 mmol compound III-1, III-3, III-4, III-6, III-7, III-8, III-9, III respectively -10 reaction, compounds I-85, I-86, I-87, I-88, I-89, I-90, I-91, I-92 can be prepared respectively, and the yields are 80%, 86% respectively , 89%, 85%, 88%, 83%, 82%, 81%.
实施例42Example 42
按照实施例1的方法,由1毫摩尔化合物I-85、I-86、I-87、I-88、I-89、I-90、I-91、I-92分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-93、I-94、I-95、I-96、I-97、I-98、I-99、I-100,产率分别为38%、46%、45%、43%、45%、46%、41%、40%。According to the method of Example 1, by 1 mmol compound I-85, I-86, I-87, I-88, I-89, I-90, I-91, I-92 and 1 mmol compound CH 3 MgI reaction, compounds I-93, I-94, I-95, I-96, I-97, I-98, I-99, I-100 can be prepared respectively, and the yields are 38% and 46% respectively , 45%, 43%, 45%, 46%, 41%, 40%.
实施例43Example 43
按照实施例1和实施例13的方法,由1毫摩尔化合物I-85、I-86、I-87、I-88、I-89、I-90、I-91、I-92分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-101、I-102、I-103、I-104、I-105、I-106、I-107、I-108,产率分别为28%、31%、37%、36%、35%、33%、35%、32%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-85, I-86, I-87, I-88, I-89, I-90, I-91, I-92 respectively with 1 Millimole compound NaCN reaction, can make compound I-101, I-102, I-103, I-104, I-105, I-106, I-107, I-108 respectively, productive rate is respectively 28%, 31%, 37%, 36%, 35%, 33%, 35%, 32%.
实施例44Example 44
按照实施例25的方法,由1毫摩尔化合物II-14分别与1毫摩尔化合物III-1、III-3、III-4、III-6、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-109、I-110、I-111、I-112、I-113、I-114、I-115、I-116,产率分别为8%、18%、14%、15%、17%、12%、11%、9%。According to the method of Example 25, by 1 mmol compound II-14 and 1 mmol compound III-1, III-3, III-4, III-6, III-7, III-8, III-9, III -10 reaction, compounds I-109, I-110, I-111, I-112, I-113, I-114, I-115, I-116 can be prepared respectively, and the yields are 8% and 18% respectively , 14%, 15%, 17%, 12%, 11%, 9%.
实施例45Example 45
按照实施例1的方法,由1毫摩尔化合物II-15分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-117、I-118、I-119、I-120、I-121、I-122、I-123、I-124,产率分别为75%、82%、83%、73%、88%、83%、84%、82%。According to the method of Example 1, by 1 mmol compound II-15 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III respectively -10 reaction, compounds I-117, I-118, I-119, I-120, I-121, I-122, I-123, I-124 can be prepared respectively, and the yields are 75%, 82% respectively , 83%, 73%, 88%, 83%, 84%, 82%.
实施例46Example 46
按照实施例1的方法,由1毫摩尔化合物I-117、I-118、I-119、I-120、I-121、I-122、I-123、I-124分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-125、I-126、I-127、I-128、I-129、I-130、I-131、I-132,产率分别为35%、41%、43%、45%、44%、46%、43%、41%。According to the method of Example 1, by 1 mmol compound I-117, I-118, I-119, I-120, I-121, I-122, I-123, I-124 respectively with 1 mmol compound CH 3 MgI reaction, compounds I-125, I-126, I-127, I-128, I-129, I-130, I-131, I-132 can be prepared respectively, and the yields are 35% and 41% respectively , 43%, 45%, 44%, 46%, 43%, 41%.
实施例47Example 47
按照实施例1和实施例13的方法,由1毫摩尔化合物I-117、I-118、I-119、I-120、I-121、I-122、I-123、I-124分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-133、I-134、I-135、I-136、I-137、I-138、I-139、I-140,产率分别为25%、30%、33%、35%、37%、34%、31%、33%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-117, I-118, I-119, I-120, I-121, I-122, I-123, I-124 respectively with 1 Millimole compound NaCN reaction, can make compound I-133, I-134, I-135, I-136, I-137, I-138, I-139, I-140 respectively, productive rate is respectively 25%, 30%, 33%, 35%, 37%, 34%, 31%, 33%.
实施例48Example 48
按照实施例1的方法,由1毫摩尔化合物II-15分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-141、I-142、I-143、I-144、I-145、I-146、I-147、I-148,产率分别为9%、16%、13%、5%、18%、14%、11%、12%。According to the method of Example 1, by 1 mmol compound II-15 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III respectively -10 reactions, compounds I-141, I-142, I-143, I-144, I-145, I-146, I-147, and I-148 can be prepared respectively, with yields of 9% and 16% respectively , 13%, 5%, 18%, 14%, 11%, 12%.
实施例49Example 49
按照实施例1的方法,由1毫摩尔化合物II-16分别与1毫摩尔化合物III-1、III-2、III-3、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-149、I-150、I-151、I-152、I-153、I-154、I-155、I-156,产率分别为75%、84%、85%、87%、72%、89%、85%、83%。According to the method of Example 1, by 1 mmol compound II-16 and 1 mmol compound III-1, III-2, III-3, III-5, III-7, III-8, III-9, III respectively -10 reaction, compounds I-149, I-150, I-151, I-152, I-153, I-154, I-155, I-156 can be prepared respectively, and the yields are 75%, 84% respectively , 85%, 87%, 72%, 89%, 85%, 83%.
实施例50Example 50
按照实施例1的方法,由1毫摩尔化合物I-149、I-150、I-151、I-152、I-153、I-154、I-155、I-156分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-157、I-158、I-159、I-160、I-161、I-162、I-163、I-164,产率分别为37%、42%、44%、40%、48%、45%、41%、41%。According to the method of Example 1, by 1 mmol compound I-149, I-150, I-151, I-152, I-153, I-154, I-155, I-156 respectively with 1 mmol compound CH 3 MgI reaction, compounds I-157, I-158, I-159, I-160, I-161, I-162, I-163, I-164 can be prepared respectively, and the yields are 37% and 42% respectively , 44%, 40%, 48%, 45%, 41%, 41%.
实施例51Example 51
按照实施例1和实施例13的方法,由1毫摩尔化合物I-149、I-150、I-151、I-152、I-153、I-154、I-155、I-156分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-165、I-166、I-167、I-168、I-169、I-170、I-171、I-172,产率分别为26%、31%、33%、32%、36%、35%、32%、33%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-149, I-150, I-151, I-152, I-153, I-154, I-155, I-156 respectively with 1 Millimole compound NaCN reaction, can make compound I-165, I-166, I-167, I-168, I-169, I-170, I-171, I-172 respectively, productive rate is respectively 26%, 31%, 33%, 32%, 36%, 35%, 32%, 33%.
实施例52Example 52
按照实施例1的方法,由1毫摩尔化合物II-16分别与1毫摩尔化合物III-1、III-2、III-3、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-173、I-174、I-175、I-176、I-177、I-178、I-179、I-180,产率分别为8%、12%、11%、7%、15%、12%、13%、14%。According to the method of Example 1, by 1 mmol compound II-16 and 1 mmol compound III-1, III-2, III-3, III-5, III-7, III-8, III-9, III respectively -10 reaction, compounds I-173, I-174, I-175, I-176, I-177, I-178, I-179, I-180 can be prepared respectively, and the yields are 8%, 12% respectively , 11%, 7%, 15%, 12%, 13%, 14%.
实施例53Example 53
按照实施例1的方法,由1毫摩尔化合物II-17分别与1毫摩尔化合物III-2、III-3、III-4、III-6、III-7、III-8、III-9、III-11反应,可以分别制得化合物I-181、I-182、I-183、I-184、I-185、I-186、I-187、I-188,产率分别为85%、87%、86%、89%、89%、85%、83%、80%。According to the method of Example 1, by 1 mmol compound II-17 and 1 mmol compound III-2, III-3, III-4, III-6, III-7, III-8, III-9, III respectively -11 reaction, compounds I-181, I-182, I-183, I-184, I-185, I-186, I-187, I-188 can be prepared respectively, and the yields are 85%, 87% respectively , 86%, 89%, 89%, 85%, 83%, 80%.
实施例54Example 54
按照实施例1的方法,由1毫摩尔化合物I-181、I-182、I-183、I-184、I-185、I-186、I-187、I-188分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-189、I-190、I-191、I-192、I-193、I-194、I-195、I-196,产率分别为39%、42%、44%、45%、47%、46%、42%、43%。According to the method of Example 1, by 1 mmol compound I-181, I-182, I-183, I-184, I-185, I-186, I-187, I-188 and 1 mmol compound CH 3 MgI reaction, compounds I-189, I-190, I-191, I-192, I-193, I-194, I-195, I-196 can be prepared respectively, and the yields are 39% and 42% respectively , 44%, 45%, 47%, 46%, 42%, 43%.
实施例55Example 55
按照实施例1和实施例13的方法,由1毫摩尔化合物I-181、I-182、I-183、I-184、I-185、I-186、I-187、I-188分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-197、I-198、I-199、I-200、I-201、I-202、I-203、I-204,产率分别为29%、31%、32%、36%、35%、34%、31%、32%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-181, I-182, I-183, I-184, I-185, I-186, I-187, I-188 respectively with 1 Millimole compound NaCN reaction, can make compound I-197, I-198, I-199, I-200, I-201, I-202, I-203, I-204 respectively, productive rate is respectively 29%, 31%, 32%, 36%, 35%, 34%, 31%, 32%.
实施例56Example 56
按照实施例1的方法,由1毫摩尔化合物II-17分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-205、I-206、I-207、I-208、I-209、I-210、I-211、I-212,产率分别为10%、12%、14%、17%、20%、15%、13%、12%。According to the method of Example 1, by 1 mmol compound II-17 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III respectively -10 reaction, compounds I-205, I-206, I-207, I-208, I-209, I-210, I-211, I-212 can be prepared respectively, and the yields are 10%, 12% respectively , 14%, 17%, 20%, 15%, 13%, 12%.
实施例57Example 57
按照实施例1的方法,由1毫摩尔化合物II-18分别与1毫摩尔化合物III-2、III-3、III-4、III-6、III-7、III-8、III-9、III-11反应,可以分别制得化合物I-213、I-214、I-215、I-216、I-217、I-218、I-219、I-220,产率分别为72%、81%、79%、63%、84%、81%、80%、76%。According to the method of Example 1, by 1 mmol compound II-18 and 1 mmol compound III-2, III-3, III-4, III-6, III-7, III-8, III-9, III respectively -11 reaction, compounds I-213, I-214, I-215, I-216, I-217, I-218, I-219, I-220 can be prepared respectively, and the yields are 72%, 81% respectively , 79%, 63%, 84%, 81%, 80%, 76%.
实施例58Example 58
按照实施例1的方法,由1毫摩尔化合物I-213、I-214、I-215、I-216、I-217、I-218、I-219、I-220分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-221、I-222、I-223、I-224、I-225、I-226、I-227、I-228,产率分别为33%、38%、40%、35%、44%、43%、41%、42%。According to the method of Example 1, by 1 mmol compound I-213, I-214, I-215, I-216, I-217, I-218, I-219, I-220 respectively with 1 mmol compound CH 3 MgI reaction, compounds I-221, I-222, I-223, I-224, I-225, I-226, I-227, I-228 can be prepared respectively, and the yields are 33% and 38% respectively , 40%, 35%, 44%, 43%, 41%, 42%.
实施例59Example 59
按照实施例1和实施例13的方法,由1毫摩尔化合物I-213、I-214、I-215、I-216、I-217、I-218、I-219、I-220分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-229、I-230、I-231、I-232、I-233、I-234、I-235、I-236,产率分别为27%、32%、34%、30%、36%、33%、31%、30%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-213, I-214, I-215, I-216, I-217, I-218, I-219, I-220 respectively with 1 Millimole compound NaCN reaction, can make compound I-229, I-230, I-231, I-232, I-233, I-234, I-235, I-236 respectively, productive rate is respectively 27%, 32%, 34%, 30%, 36%, 33%, 31%, 30%.
实施例60Example 60
按照实施例1的方法,由1毫摩尔化合物II-18分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-237、I-238、I-239、I-240、I-241、I-242、I-243、I-244,产率分别为7%、12%、13%、8%、16%、12%、9%、10%。According to the method of Example 1, by 1 mmol compound II-18 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III respectively -10 reaction, compounds I-237, I-238, I-239, I-240, I-241, I-242, I-243, I-244 can be prepared respectively, and the yields are 7%, 12% respectively , 13%, 8%, 16%, 12%, 9%, 10%.
实施例61Example 61
按照实施例1的方法,由1毫摩尔化合物II-19分别与1毫摩尔化合物III-2、III-3、III-4、III-6、III-7、III-8、III-9、III-11反应,可以分别制得化合物I-245、I-246、I-247、I-248、I-249、I-250、I-251、I-252,产率分别为81%、84%、86%、73%、88%、85%、84%、83%。According to the method of Example 1, by 1 mmol compound II-19 and 1 mmol compound III-2, III-3, III-4, III-6, III-7, III-8, III-9, III respectively -11 reaction, compounds I-245, I-246, I-247, I-248, I-249, I-250, I-251, I-252 can be prepared respectively, and the yields are 81%, 84% respectively , 86%, 73%, 88%, 85%, 84%, 83%.
实施例62Example 62
按照实施例1的方法,由1毫摩尔化合物I-245、I-246、I-247、I-248、I-249、I-250、I-251、I-252分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-253、I-254、I-255、I-256、I-257、I-258、I-259、I-260,产率分别为37%、42%、43%、35%、44%、43%、42%、40%。According to the method of Example 1, by 1 mmol compound I-245, I-246, I-247, I-248, I-249, I-250, I-251, I-252 respectively with 1 mmol compound CH 3 MgI reaction, compounds I-253, I-254, I-255, I-256, I-257, I-258, I-259, I-260 can be prepared respectively, and the yields are 37% and 42% respectively , 43%, 35%, 44%, 43%, 42%, 40%.
实施例63Example 63
按照实施例1和实施例13的方法,由1毫摩尔化合物I-245、I-246、I-247、I-248、I-249、I-250、I-251、I-252分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-261、I-262、I-263、I-264、I-265、I-266、I-267、I-268,产率分别为28%、31%、33%、32%、36%、34%、32%、33%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-245, I-246, I-247, I-248, I-249, I-250, I-251, I-252 respectively with 1 Millimole compound NaCN reaction, can make compound I-261, I-262, I-263, I-264, I-265, I-266, I-267, I-268 respectively, productive rate is respectively 28%, 31%, 33%, 32%, 36%, 34%, 32%, 33%.
实施例64Example 64
按照实施例1的方法,由1毫摩尔化合物II-19分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-269、I-270、I-271、I-272、I-273、I-274、I-275、I-276,产率分别为11%、14%、13%、9%、16%、15%、13%、11%。According to the method of Example 1, by 1 mmol compound II-19 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III respectively -10 reactions, compounds I-269, I-270, I-271, I-272, I-273, I-274, I-275, I-276 can be prepared respectively, and the yields are 11%, 14% respectively , 13%, 9%, 16%, 15%, 13%, 11%.
实施例65Example 65
按照实施例1的方法,由1毫摩尔化合物II-20分别与1毫摩尔化合物III-2、III-3、III-4、III-6、III-7、III-8、III-9、III-11反应,可以分别制得化合物I-277、I-278、I-279、I-280、I-281、I-282、I-283、I-284,产率分别为82%、84%、85%、71%、86%、88%、85%、82%。According to the method of Example 1, by 1 mmol compound II-20 and 1 mmol compound III-2, III-3, III-4, III-6, III-7, III-8, III-9, III -11 reaction, compounds I-277, I-278, I-279, I-280, I-281, I-282, I-283, I-284 can be prepared respectively, and the yields are 82%, 84% respectively , 85%, 71%, 86%, 88%, 85%, 82%.
实施例66Example 66
按照实施例1的方法,由1毫摩尔化合物I-277、I-278、I-279、I-280、I-281、I-282、I-283、I-284分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-285、I-286、I-287、I-288、I-289、I-290、I-291、I-292,产率分别为36%、42%、43%、34%、45%、47%、42%、41%。According to the method of Example 1, by 1 mmol compound I-277, I-278, I-279, I-280, I-281, I-282, I-283, I-284 and 1 mmol compound CH 3 MgI reaction, compounds I-285, I-286, I-287, I-288, I-289, I-290, I-291, I-292 can be prepared respectively, and the yields are 36% and 42% respectively , 43%, 34%, 45%, 47%, 42%, 41%.
实施例67Example 67
按照实施例1和实施例13的方法,由1毫摩尔化合物I-277、I-278、I-279、I-280、I-281、I-282、I-283、I-284分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-293、I-294、I-295、I-296、I-297、I-298、I-299、I-300,产率分别为28%、32%、33%、31%、37%、38%、34%、32%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-277, I-278, I-279, I-280, I-281, I-282, I-283, I-284 respectively with 1 Millimole compound NaCN reaction, can make compound I-293, I-294, I-295, I-296, I-297, I-298, I-299, I-300 respectively, and productive rate is respectively 28%, 32%, 33%, 31%, 37%, 38%, 34%, 32%.
实施例68Example 68
按照实施例1的方法,由1毫摩尔化合物II-20分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-301、I-302、I-303、I-304、I-305、I-306、I-307、I-308,产率分别为9%、12%、13%、8%、14%、16%、13%、10%。According to the method of Example 1, by 1 mmol compound II-20 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III -10 reactions, compounds I-301, I-302, I-303, I-304, I-305, I-306, I-307, and I-308 can be prepared respectively, with yields of 9% and 12% respectively , 13%, 8%, 14%, 16%, 13%, 10%.
实施例69Example 69
按照实施例1的方法,由1毫摩尔化合物II-21分别与1毫摩尔化合物III-2、III-3、III-4、III-6、III-7、III-8、III-9、III-11反应,可以分别制得化合物I-309、I-310、I-311、I-312、I-313、I-314、I-315、I-316,产率分别为80%、82%、81%、69%、84%、85%、82%、78%。According to the method of Example 1, by 1 mmol compound II-21 and 1 mmol compound III-2, III-3, III-4, III-6, III-7, III-8, III-9, III -11 reaction, compounds I-309, I-310, I-311, I-312, I-313, I-314, I-315, I-316 can be prepared respectively, and the yields are 80% and 82% respectively , 81%, 69%, 84%, 85%, 82%, 78%.
实施例70Example 70
按照实施例1的方法,由1毫摩尔化合物I-309、I-310、I-311、I-312、I-313、I-314、I-315、I-316分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-317、I-318、I-319、I-320、I-321、I-322、I-323、I-324,产率分别为33%、39%、41%、32%、43%、45%、40%、38%。According to the method of Example 1, by 1 mmol compound I-309, I-310, I-311, I-312, I-313, I-314, I-315, I-316 respectively with 1 mmol compound CH 3 MgI reaction, compounds I-317, I-318, I-319, I-320, I-321, I-322, I-323, I-324 can be prepared respectively, and the yields are 33% and 39% respectively , 41%, 32%, 43%, 45%, 40%, 38%.
实施例71Example 71
按照实施例1和实施例13的方法,由1毫摩尔化合物I-309、I-310、I-311、I-312、I-313、I-314、I-315、I-316分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-325、I-326、I-327、I-328、I-329、I-330、I-331、I-332,产率分别为27%、30%、32%、31%、34%、36%、32%、30%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-309, I-310, I-311, I-312, I-313, I-314, I-315, I-316 respectively with 1 Millimole compound NaCN reaction, can make compound I-325, I-326, I-327, I-328, I-329, I-330, I-331, I-332 respectively, productive rate is respectively 27%, 30%, 32%, 31%, 34%, 36%, 32%, 30%.
实施例72Example 72
按照实施例1的方法,由1毫摩尔化合物II-21分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-333、I-334、I-335、I-336、I-337、I-338、I-339、I-340,产率分别为7%、11%、12%、6%、14%、15%、13%、11%。According to the method of Example 1, by 1 mmol compound II-21 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III respectively -10 reaction, compounds I-333, I-334, I-335, I-336, I-337, I-338, I-339, I-340 can be prepared respectively, and the yields are 7%, 11% respectively , 12%, 6%, 14%, 15%, 13%, 11%.
实施例73Example 73
按照实施例1的方法,由1毫摩尔化合物II-22分别与1毫摩尔化合物III-2、III-3、III-4、III-6、III-7、III-8、III-9、III-11反应,可以分别制得化合物I-341、I-342、I-343、I-344、I-345、I-346、I-347、I-348,产率分别为75%、74%、69%、78%、83%、81%、78%、73%。According to the method of Example 1, by 1 mmol compound II-22 and 1 mmol compound III-2, III-3, III-4, III-6, III-7, III-8, III-9, III -11 reaction, compounds I-341, I-342, I-343, I-344, I-345, I-346, I-347, I-348 can be prepared respectively, and the yields are 75%, 74% respectively , 69%, 78%, 83%, 81%, 78%, 73%.
实施例74Example 74
按照实施例1的方法,由1毫摩尔化合物I-341、I-342、I-343、I-344、I-345、I-346、I-347、I-348分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-349、I-350、I-351、I-352、I-353、I-354、I-355、I-356,产率分别为32%、41%、30%、42%、44%、40%、42%、33%。According to the method of Example 1, by 1 mmol compound I-341, I-342, I-343, I-344, I-345, I-346, I-347, I-348 and 1 mmol compound CH 3 MgI reaction, compounds I-349, I-350, I-351, I-352, I-353, I-354, I-355, I-356 can be prepared respectively, and the yields are 32% and 41% respectively , 30%, 42%, 44%, 40%, 42%, 33%.
实施例75Example 75
按照实施例1和实施例13的方法,由1毫摩尔化合物I-341、I-342、I-343、I-344、I-345、I-346、I-347、I-348分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-357、I-358、I-359、I-360、I-361、I-362、I-363、I-364,产率分别为23%、28%、25%、30%、33%、34%、30%、28%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-341, I-342, I-343, I-344, I-345, I-346, I-347, I-348 respectively with 1 Millimole compound NaCN reaction, can make compound I-357, I-358, I-359, I-360, I-361, I-362, I-363, I-364 respectively, productive rate is respectively 23%, 28%, 25%, 30%, 33%, 34%, 30%, 28%.
实施例76Example 76
按照实施例1的方法,由1毫摩尔化合物II-22分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-365、I-366、I-367、I-368、I-369、I-370、I-371、I-372,产率分别为6%、11%、5%、12%、14%、11%、12%、10%。According to the method of Example 1, by 1 mmol compound II-22 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III respectively -10 reaction, compounds I-365, I-366, I-367, I-368, I-369, I-370, I-371, I-372 can be prepared respectively, and the yields are 6% and 11% respectively , 5%, 12%, 14%, 11%, 12%, 10%.
实施例77Example 77
按照实施例1的方法,由1毫摩尔化合物II-23分别与1毫摩尔化合物III-2、III-3、III-4、III-6、III-7、III-8、III-9、III-11反应,可以分别制得化合物I-373、I-374、I-375、I-376、I-377、I-378、I-379、I-380,产率分别为81%、82%、79%、85%、87%、84%、82%、83%。According to the method of Example 1, by 1 mmol compound II-23 and 1 mmol compound III-2, III-3, III-4, III-6, III-7, III-8, III-9, III respectively -11 reaction, compounds I-373, I-374, I-375, I-376, I-377, I-378, I-379, I-380 can be prepared respectively, and the yields are 81%, 82% respectively , 79%, 85%, 87%, 84%, 82%, 83%.
实施例78Example 78
按照实施例1的方法,由1毫摩尔化合物I-373、I-374、I-375、I-376、I-377、I-378、I-379、I-380分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-381、I-382、I-383、I-384、I-385、I-386、I-387、I-388,产率分别为34%、41%、33%、44%、47%、45%、41%、42%。According to the method of Example 1, by 1 mmol compound I-373, I-374, I-375, I-376, I-377, I-378, I-379, I-380 respectively with 1 mmol compound CH 3 MgI reaction, compounds I-381, I-382, I-383, I-384, I-385, I-386, I-387, I-388 can be prepared respectively, and the yields are 34% and 41% respectively , 33%, 44%, 47%, 45%, 41%, 42%.
实施例79Example 79
按照实施例1和实施例13的方法,由1毫摩尔化合物I-373、I-374、I-375、I-376、I-377、I-378、I-379、I-380分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-389、I-390、I-391、I-392、I-393、I-394、I-395、I-396,产率分别为27%、31%、30%、33%、35%、34%、31%、32%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-373, I-374, I-375, I-376, I-377, I-378, I-379, I-380 respectively with 1 Millimole compound NaCN reaction, can make compound I-389, I-390, I-391, I-392, I-393, I-394, I-395, I-396 respectively, and productive rate is respectively 27%, 31%, 30%, 33%, 35%, 34%, 31%, 32%.
实施例80Example 80
按照实施例1的方法,由1毫摩尔化合物II-23分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-397、I-398、I-399、I-400、I-401、I-402、I-403、I-404,产率分别为9%、14%、13%、7%、16%、15%、11%、13%。According to the method of Example 1, by 1 mmol compound II-23 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III respectively -10 reactions, compounds I-397, I-398, I-399, I-400, I-401, I-402, I-403, and I-404 can be prepared respectively, with yields of 9% and 14% respectively , 13%, 7%, 16%, 15%, 11%, 13%.
实施例81Example 81
按照实施例1的方法,由1毫摩尔化合物II-24分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-405、I-406、I-407、I-408、I-409、I-410、I-411、I-412,产率分别为81%、85%、84%、72%、83%、87%、82%、79%。According to the method of Example 1, by 1 mmol compound II-24 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III respectively -10 reactions, compounds I-405, I-406, I-407, I-408, I-409, I-410, I-411, I-412 can be prepared respectively, and the yields are 81%, 85% respectively , 84%, 72%, 83%, 87%, 82%, 79%.
实施例82Example 82
按照实施例1的方法,由1毫摩尔化合物I-405、I-406、I-407、I-408、I-409、I-410、I-411、I-412分别与1毫摩尔化合物CH3MgI反应,可以分别制得化合物I-413、I-414、I-415、I-416、I-417、I-418、I-419、I-420,产率分别为35%、43%、42%、40%、44%、46%、41%、42%。According to the method of Example 1, by 1 mmol compound I-405, I-406, I-407, I-408, I-409, I-410, I-411, I-412 respectively with 1 mmol compound CH 3 MgI reaction, compounds I-413, I-414, I-415, I-416, I-417, I-418, I-419, I-420 can be prepared respectively, and the yields are 35% and 43% respectively , 42%, 40%, 44%, 46%, 41%, 42%.
实施例83Example 83
按照实施例1和实施例13的方法,由1毫摩尔化合物I-405、I-406、I-407、I-408、I-409、I-410、I-411、I-412分别与1毫摩尔化合物NaCN反应,可以分别制得化合物I-421、I-422、I-423、I-424、I-425、I-426、I-427、I-428,产率分别为29%、32%、33%、30%、35%、37%、34%、33%。According to the method of embodiment 1 and embodiment 13, by 1 mmol compound I-405, I-406, I-407, I-408, I-409, I-410, I-411, I-412 respectively with 1 Millimole compound NaCN reaction, can make compound I-421, I-422, I-423, I-424, I-425, I-426, I-427, I-428 respectively, productive rate is respectively 29%, 32%, 33%, 30%, 35%, 37%, 34%, 33%.
实施例84Example 84
按照实施例1的方法,由1毫摩尔化合物II-24分别与1毫摩尔化合物III-1、III-2、III-4、III-5、III-7、III-8、III-9、III-10反应,可以分别制得化合物I-429、I-430、I-431、I-432、I-433、I-434、I-435、I-436,产率分别为10%、16%、17%、11%、19%、21%、15%、13%。According to the method of Example 1, by 1 mmol compound II-24 and 1 mmol compound III-1, III-2, III-4, III-5, III-7, III-8, III-9, III respectively -10 reactions, compounds I-429, I-430, I-431, I-432, I-433, I-434, I-435, I-436 can be prepared respectively, and the yields are 10%, 16% respectively , 17%, 11%, 19%, 21%, 15%, 13%.
实施例84Example 84
重复实施例1制备化合物I-1的方法,区别在于,将加热温度100℃改成“60℃”,反应时间改为4h,其余条件不变,制备得到具有结构式I的化合物。The method for preparing compound I-1 in Example 1 was repeated, with the difference that the heating temperature was changed from 100°C to "60°C", the reaction time was changed to 4h, and the rest of the conditions were kept unchanged to prepare a compound with structural formula I.
按照上述实施例1-84的制备方法,可制得的产物结构I中,R1、R2、R6、R7可分别独立的为氢、低级烃基、醚基、取代烷基或酰基;R3、R4、R5、R8、R9、R10分别独立的为氢、低级烃基或卤素;R11为氢、甲基、氰基或三氟甲基;为阴离子;According to the preparation method of the above-mentioned Examples 1-84, in the product structure I that can be obtained, R 1 , R 2 , R 6 , and R 7 can be independently hydrogen, lower hydrocarbon group, ether group, substituted alkyl group or acyl group; R 3 , R 4 , R 5 , R 8 , R 9 , and R 10 are independently hydrogen, lower hydrocarbon or halogen; R 11 is hydrogen, methyl, cyano or trifluoromethyl; is an anion;
其中,R1、R2、R6、R7中低级烃基可为直链、支链或环状;所述烃基包含1-6个碳原子;Wherein, the lower hydrocarbon groups in R 1 , R 2 , R 6 , and R 7 can be linear, branched or cyclic; the hydrocarbon groups contain 1-6 carbon atoms;
其中,R1、R2、R6、R7中醚基中碳原子数为3~6,氧原子数≤2;Among them, the number of carbon atoms in the ether group in R 1 , R 2 , R 6 , and R 7 is 3-6, and the number of oxygen atoms is ≤2;
其中,R1、R2、R6、R7中取代烷基为直链或支链;所述取代烷基为ω-甲酸酯基取代1-6个碳原子烷基、ω-甲酰胺基取代1-6个碳原子烷基、ω-卤素取代1-6个碳原子烷基、ω-羟基取代1-6个碳原子烷基、ω-氨基取代1-6个碳原子烷基或ω-巯基取代1-6个碳原子烷基;其中,所述ω-甲酸酯基取代1-6个碳原子烷基中甲酸酯基为2-5个碳原子烷基甲酸酯基;所述的ω-甲酰胺基取代1-6个碳原子烷基中甲酰胺基为2-5个碳原子烃基甲酰胺基;Among them, the substituted alkyl groups in R 1 , R 2 , R 6 , and R 7 are linear or branched; Substituting 1-6 carbon atom alkyl group, ω-halogen substituting 1-6 carbon atom alkyl group, ω-hydroxyl substituting 1-6 carbon atom alkyl group, ω-amino group substituting 1-6 carbon atom alkyl group or ω-mercapto substituted 1-6 carbon atom alkyl; wherein, the ω-formate group is 2-5 carbon atom alkyl formate group in the substituted 1-6 carbon atom alkyl ; The carboxamide group in the ω-formamide group substituting the 1-6 carbon atom alkyl group is a 2-5 carbon atom hydrocarbon group formamide group;
其中,R1、R2、R6、R7中酰基为2-6个碳原子烷基酰基、叔丁氧羰基、苯甲酰基、1-6个碳原子取代苯甲酰基或卤素取代苯甲酰基;所述R11为氢、甲基、氰基、或三氟甲基;Among them, the acyl group in R 1 , R 2 , R 6 , and R 7 is an alkylacyl group with 2-6 carbon atoms, tert-butoxycarbonyl, benzoyl, benzoyl with 1-6 carbon atoms or halogen-substituted benzoyl Acyl; The R 11 is hydrogen, methyl, cyano or trifluoromethyl;
其中卤素为氟、氯、溴或碘。Wherein halogen is fluorine, chlorine, bromine or iodine.
本发明所得近红外的高量子产率染料应用于核仁RNA荧光标记实验:The obtained near-infrared high quantum yield dyes of the present invention are applied to nucleolar RNA fluorescent labeling experiments:
根据公开号为:CN103725758A的中国发明专利中提供的“近红外生物荧光染料在活细胞成像的应用”中的方法,将本发明实施例3、7、15、16、27、28、37、40、42、54、62、77中得到的具有结构式I的荧光染料化合物I-6、I-15、I-29、I-30、I-42、I-43、I-54、I-78、I-95、I-191、I-255、I-393应用于对A549细胞和Hela细胞核仁RNA的荧光标记,区别在于,步骤3)中染料溶液的最终浓度为400-450nM,结果分别如图1-14所示。从图1-14中均可以看出在配制较低浓度的染料溶液的条件下,该系列染料对细胞质染色的同时,也对细胞核内核仁也染色,图中细胞质有荧光,细胞核里的核仁也有荧光,整个染色范围均较大。且染料的荧光量子产量高、染色所需的染料浓度也很低,避免了高浓度染料对活细胞正常的生理功能造成某些干扰以及降低了细胞的毒性。According to the method in the "Application of Near-infrared Bioluminescent Dyes in Live Cell Imaging" provided in the Chinese invention patent with publication number CN103725758A, the embodiments of the present invention 3, 7, 15, 16, 27, 28, 37, 40 Fluorescent dye compounds I-6, I-15, I-29, I-30, I-42, I-43, I-54, I-78, I-95, I-191, I-255, and I-393 are applied to the fluorescent labeling of nucleolar RNA in A549 cells and Hela cells. The difference is that the final concentration of the dye solution in step 3) is 400-450nM, and the results are shown in Fig. 1-14 shown. It can be seen from Figure 1-14 that under the condition of preparing a lower concentration of dye solution, this series of dyes stains the cytoplasm and also stains the nucleus and inner kernel. In the figure, the cytoplasm has fluorescence, and the nucleolus in the nucleus also has fluorescence. Fluorescence, the entire staining range is large. Moreover, the fluorescence quantum yield of the dye is high, and the dye concentration required for dyeing is also very low, which avoids certain interference of the high concentration dye on the normal physiological functions of living cells and reduces the toxicity of the cells.
将本发明所得化合物染料I-54和I-78分别加DNA酶和RNA酶消化并与市售的DNA、RNA染料对比,如图15所示,结果说明化合物I-54和I-78进入细胞核所染的为核仁RNA。Compound dyes I-54 and I-78 obtained by the present invention were digested with DNase and RNase respectively and compared with commercially available DNA and RNA dyes, as shown in Figure 15, the results show that compounds I-54 and I-78 enter the nucleus Stained for nucleolar RNA.
将本发明所得化合物染料I-54和I-78分别与市售RNA染料SYTO RNASelect的细胞染色效果对比,如图16所示,结果说明I-54和I-78比SYTO RNASelect具有更好的核仁RNA染色,并且对细胞的损伤小、降低了背景荧光的干扰。Comparing the cell staining effects of the obtained compound dyes I-54 and I-78 of the present invention with the commercially available RNA dye SYTO RNASelect respectively, as shown in Figure 16, the results show that I-54 and I-78 have better nuclei than SYTO RNASelect Kernel RNA staining, and the damage to the cells is small, reducing the interference of background fluorescence.
显然,本发明的上述实施例仅仅是为清楚地说明本发明所作的举例,而并非是对本发明的实施方式的限定,对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动,这里无法对所有的实施方式予以穷举,凡是属于本发明的技术方案所引伸出的显而易见的变化或变动仍处于本发明的保护范围之列。Apparently, the above-mentioned embodiments of the present invention are only examples for clearly illustrating the present invention, and are not intended to limit the implementation of the present invention. Those of ordinary skill in the art can also make It is impossible to exhaustively list all the implementation modes here, and any obvious changes or changes derived from the technical solutions of the present invention are still within the scope of protection of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610115507.0A CN107141840B (en) | 2016-03-01 | 2016-03-01 | Near-infrared high-quantum-yield dye and preparation and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610115507.0A CN107141840B (en) | 2016-03-01 | 2016-03-01 | Near-infrared high-quantum-yield dye and preparation and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107141840A true CN107141840A (en) | 2017-09-08 |
| CN107141840B CN107141840B (en) | 2019-03-12 |
Family
ID=59783087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610115507.0A Expired - Fee Related CN107141840B (en) | 2016-03-01 | 2016-03-01 | Near-infrared high-quantum-yield dye and preparation and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107141840B (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107286926A (en) * | 2016-04-11 | 2017-10-24 | 中国科学院理化技术研究所 | Hybrid fluorescent dye based on coumarin and fluorescein, and preparation method and application thereof |
| CN110452686A (en) * | 2019-05-10 | 2019-11-15 | 长沙理工大学 | A kind of cytoplasmic protein-assisted enhanced anthocyanin-like fluorescent dye and preparation method thereof |
| CN111718319A (en) * | 2020-07-27 | 2020-09-29 | 山西大学 | Fluorescent probe for differential detection of thiols and monitoring of Cys/GSH metabolism and preparation method thereof |
| CN112920157A (en) * | 2021-02-03 | 2021-06-08 | 山西大学 | Benzene coupling benzopyran derivative and synthetic method and application thereof |
| WO2023208867A1 (en) * | 2022-04-25 | 2023-11-02 | Integrative Research Laboratories Sweden Ab | NOVEL 1,2,3,4,4a,5,8,9,10,10a-DECAHYDROBENZO[G]QUINOLIN-6(7H)-ONE COMPOUNDS AND USES THEREOF |
| CN117551069A (en) * | 2023-11-21 | 2024-02-13 | 临沂大学 | A near-infrared methylxanthene dye and its preparation method and application |
| CN119462678A (en) * | 2025-01-17 | 2025-02-18 | 安徽中医药大学 | A fluorescent probe for detecting metal palladium, a fluorescent nanofiber membrane, and a preparation method and application thereof |
| CN119708040A (en) * | 2025-02-26 | 2025-03-28 | 安徽中医药大学 | A selective hydrogen peroxide fluorescent probe and preparation method, kit and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130288911A1 (en) * | 2008-01-24 | 2013-10-31 | Life Technologies Corporation | Fluorogenic hydrazine-substituted compounds |
| CN103725758A (en) * | 2012-10-10 | 2014-04-16 | 中国科学院理化技术研究所 | Application of near-infrared biological fluorescent dye in living cell imaging |
| US20140120628A1 (en) * | 2011-06-29 | 2014-05-01 | The Oregon State Board Of Higher Education On Behalf Of Portland State University | Near-infrared fluorescent dyes with large stokes shifts |
-
2016
- 2016-03-01 CN CN201610115507.0A patent/CN107141840B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130288911A1 (en) * | 2008-01-24 | 2013-10-31 | Life Technologies Corporation | Fluorogenic hydrazine-substituted compounds |
| US20140120628A1 (en) * | 2011-06-29 | 2014-05-01 | The Oregon State Board Of Higher Education On Behalf Of Portland State University | Near-infrared fluorescent dyes with large stokes shifts |
| CN103725758A (en) * | 2012-10-10 | 2014-04-16 | 中国科学院理化技术研究所 | Application of near-infrared biological fluorescent dye in living cell imaging |
Non-Patent Citations (2)
| Title |
|---|
| MARTHA SIBRIAN-VAZQUEZ ET AL.: "Progress toward red and near-infrared (NIR) emitting saccharide sensors", 《PURE APPL. CHEM.》 * |
| WEIMIN LIU ET AL.: "Deep-Red Emissive Crescent-Shaped Fluorescent Dyes: Substituent Effect on Live Cell Imaging", 《ACS APPL. MATER. INTERFACES》 * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107286926A (en) * | 2016-04-11 | 2017-10-24 | 中国科学院理化技术研究所 | Hybrid fluorescent dye based on coumarin and fluorescein, and preparation method and application thereof |
| CN107286926B (en) * | 2016-04-11 | 2019-03-26 | 中国科学院理化技术研究所 | Hybrid fluorescent dye based on coumarin and fluorescein, and preparation method and application thereof |
| CN110452686A (en) * | 2019-05-10 | 2019-11-15 | 长沙理工大学 | A kind of cytoplasmic protein-assisted enhanced anthocyanin-like fluorescent dye and preparation method thereof |
| CN111718319A (en) * | 2020-07-27 | 2020-09-29 | 山西大学 | Fluorescent probe for differential detection of thiols and monitoring of Cys/GSH metabolism and preparation method thereof |
| CN112920157A (en) * | 2021-02-03 | 2021-06-08 | 山西大学 | Benzene coupling benzopyran derivative and synthetic method and application thereof |
| CN112920157B (en) * | 2021-02-03 | 2023-03-07 | 山西大学 | A kind of benzo-coupled benzopyran derivative and its synthesis method and application |
| WO2023208867A1 (en) * | 2022-04-25 | 2023-11-02 | Integrative Research Laboratories Sweden Ab | NOVEL 1,2,3,4,4a,5,8,9,10,10a-DECAHYDROBENZO[G]QUINOLIN-6(7H)-ONE COMPOUNDS AND USES THEREOF |
| CN117551069A (en) * | 2023-11-21 | 2024-02-13 | 临沂大学 | A near-infrared methylxanthene dye and its preparation method and application |
| CN117551069B (en) * | 2023-11-21 | 2025-03-04 | 临沂大学 | Near-infrared methyl xanthene dye and preparation method and application thereof |
| CN119462678A (en) * | 2025-01-17 | 2025-02-18 | 安徽中医药大学 | A fluorescent probe for detecting metal palladium, a fluorescent nanofiber membrane, and a preparation method and application thereof |
| CN119462678B (en) * | 2025-01-17 | 2025-05-13 | 安徽中医药大学 | Fluorescent probe for detecting metal palladium, fluorescent nanofiber membrane, and preparation method and application of fluorescent probe |
| CN119708040A (en) * | 2025-02-26 | 2025-03-28 | 安徽中医药大学 | A selective hydrogen peroxide fluorescent probe and preparation method, kit and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107141840B (en) | 2019-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107141840B (en) | Near-infrared high-quantum-yield dye and preparation and application thereof | |
| EP4026831B1 (en) | Piperic acid derivative and its use as insecticide | |
| TWI831011B (en) | EGFR inhibitors, preparation methods and uses thereof | |
| IL276147B2 (en) | GCN2 inhibitors and uses thereof | |
| RU2007116725A (en) | DIAMINO-ALKANE ASPARAGIN PROTEASE INHIBITORS | |
| RU2641895C2 (en) | Heterocyclic pyrimidine analogues as tyk2 inhibitors | |
| US20100278733A1 (en) | Composition for diagnosis of amyloid-related disease | |
| RU2649398C2 (en) | Halogen substituted heterocyclic compound | |
| US6440975B1 (en) | Amino acid derivatives, the preparation and use thereof as endothelin antagonists | |
| US6670367B1 (en) | Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists | |
| US6686369B1 (en) | α-hydrdroxylic acid derivatives, their production and use | |
| IL278122B2 (en) | Petridinon compounds and their uses | |
| CA2082617C (en) | Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method | |
| US20110251212A1 (en) | Piperazine derivatives | |
| CN105732604A (en) | Compound as dye | |
| US6448248B1 (en) | Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists | |
| US20100003191A1 (en) | Aurone derivative-containing composition for diagnosis | |
| CN101940214A (en) | Control the Spiropiperidine derivatives of insect | |
| CN1261352A (en) | New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists | |
| EP4631938A1 (en) | Nitrogen-containing heterocycle with serotonin receptor-binding activity and carbocyclic derivative | |
| US5612287A (en) | N-(substituted amino) pyrrole derivatives preparation process thereof, and herbicidal compositions | |
| WO2023051261A1 (en) | Imine compound and use thereof | |
| CN102399184A (en) | Compound and dye | |
| US5683964A (en) | N-(substituted amino)imide derivatives, preparation process thereof, and herbicidal composition | |
| CN101628881B (en) | Substituted cyanoacetate compound and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190312 |